Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3028167	b-t-cd4	e9/l (—)	1820	4070	100.00%	Distribution not available
3028167	b-cd4	e6/l (e6/l)	1244	3843	0.00%
3028167	b-cd4	— (—)	125	145	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

303

232

13.64

320.53

2.9

2.3

472.31

689.03

e6/l

4.52

293

224

Other diseases of blood and blood-forming organs, wide

429

540

8.25

318.65

3.4

2.5

696.26

674.39

e6/l

0.07

407

520

Certain disorders involving the immune mechanism

410

495

8.65

315.56

2.7

689.86

675.95

e6/l

0.14

395

479

ILD medications

1313

1369

5.27

307.65

2.8

2.4

675.79

700.96

e6/l

0.71

1267

1333

Secondary uncertain malignant neoplasm

301

181

17.48

307.65

3.0

2.0

477.31

717.41

e6/l

4.84

290

173

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

963

1229

4.81

307.65

2.7

2.4

693.02

689.09

e6/l

0.03

925

1194

Primary_lymphoid and hematopoietic malignant neoplasms

875

433

21.87

307.65

3.3

2.2

513.67

670.03

e6/l

5.78

847

412

Bacterial infection, other or unspecified

697

1065

5.79

307.65

2.9

2.4

647.71

686.70

e6/l

0.21

659

1029

ILD medications: immunosuppressive drugs

954

1235

7.34

307.65

2.9

2.4

620.66

701.08

e6/l

3.92

924

1200

First line medication for Crohn's disease

1173

1370

4.68

307.65

2.7

2.5

668.73

717.84

e6/l

1.78

1129

1341

Bacterial infection, other or unspecified

736

1136

5.58

307.65

2.9

2.4

650.07

693.14

e6/l

0.26

697

1099

Non-Hodgkin lymphoma, all, including Hilmo

509

188

29.62

307.65

3.1

1.9

538.78

687.11

e6/l

2.75

493

180

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1233

1728

5.00

307.65

2.8

2.5

672.49

721.64

e6/l

0.56

1188

1678

Liquid cancers, helper endpoint

987

586

15.43

307.65

3.3

2.1

570.30

755.36

e6/l

2.86

951

565

963

1229

4.81

307.65

2.7

2.4

693.02

689.09

e6/l

0.03

925

1194

Fever of other and unknown origin

880

1079

7.42

307.65

2.9

2.4

652.03

713.16

e6/l

0.51

855

1049

Non-follicular lymphoma

365

178

22.56

307.65

3.2

1.9

456.62

693.45

e6/l

3.55

350

170

ILD medications: prednisolone, methylprednisolone, prednisone

1176

1324

5.03

307.65

2.6

2.4

688.70

702.17

e6/l

0.28

1130

1288

Oral corticosteroids

1107

1641

4.05

307.65

2.4

2.7

681.67

674.97

e6/l

0.13

1059

1603

Influenza and pneumonia

1107

1885

3.78

306.02

2.7

2.5

696.69

714.38

e6/l

0.14

1064

1838

Pneumonias (Asthma/COPD co-morbidities)

1061

1887

3.82

303.64

2.7

2.5

692.10

713.01

e6/l

0.17

1019

1839

Inflammatory bowel disease treatment related agents

1151

1730

3.76

301.51

2.4

2.7

684.52

685.40

e6/l

0.02

1102

1692

Other bacterial diseases

1005

1764

3.88

293.51

2.9

2.5

654.21

709.29

e6/l

0.52

959

1720

All pneumoniae

1054

1935

3.68

286.50

2.7

2.6

690.82

709.78

e6/l

0.15

1011

1887

Pneumonia, organism unspecified

960

1753

3.89

285.48

2.6

2.5

693.10

703.50

e6/l

0.07

923

1708

Enlarged lymph nodes

313

305

10.65

282.95

3.1

2.4

549.63

715.92

e6/l

5.03

302

295

Other bacterial diseases

1030

1802

3.67

273.44

2.9

2.5

614.37

717.23

e6/l

5.94

987

1757

Certain infectious and parasitic diseases

836

900

4.70

272.04

2.7

2.4

684.48

749.61

e6/l

1.93

806

869

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1000

1964

3.51

255.89

2.6

696.17

703.84

e6/l

0.05

961

1913

Second line medication for Crohn's disease

672

1673

4.08

238.41

2.4

2.7

637.69

698.73

e6/l

1.89

648

1624

Abnormal findings on diagnostic imaging of lung

539

1082

4.86

235.53

2.5

2.4

688.25

635.61

e6/l

0.24

515

1038

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

684

1530

4.06

233.39

2.6

2.5

721.93

667.67

e6/l

0.32

654

1476

L04AX Other immunosuppressants

648

1613

4.08

229.97

2.4

2.7

640.76

699.39

e6/l

1.70

625

1565

Autoimmune diseases related-to ILD

844

2097

3.48

228.88

2.9

2.4

740.43

683.53

e6/l

1.17

818

2032

L04AA Selective immunosuppressants

385

626

6.35

226.06

3.1

2.8

662.80

714.51

e6/l

0.77

371

609

Rare circulating lymphoid malignancy, including Hilmo

143

33.90

220.27

4.5

1.9

581.98

835.50

e6/l

1.18

133

Agranulocytosis

240

244

10.32

211.04

3.8

2.2

540.50

731.17

e6/l

2.97

226

233

Septicaemia

462

880

4.99

206.95

3.1

2.4

580.14

682.11

e6/l

3.48

436

852

Autoimmune diseases excluding thyroid diseases, strict definition

958

1641

3.23

200.62

2.8

2.5

736.22

695.17

e6/l

0.58

928

1597

Autoimmune diseases excluding thyroid diseases

977

1688

3.19

200.51

2.8

2.5

732.18

696.08

e6/l

0.50

948

1641

Other septicaemia

417

789

5.17

196.26

3.2

2.4

576.32

673.99

e6/l

2.96

391

762

Any gastric operation

635

720

4.46

195.92

2.9

2.4

707.89

817.17

e6/l

3.33

618

690

GASTRO-related operations

635

720

4.46

195.92

2.9

2.4

707.89

817.17

e6/l

3.33

618

690

Malignant neoplasm

769

1282

3.59

193.23

3.2

2.3

547.44

820.55

e6/l

8.98

742

1244

General symptoms and signs

894

1367

3.30

187.74

2.7

2.4

681.64

708.65

e6/l

0.65

860

1334

Explicit Sepsis

479

1070

4.24

175.86

3.1

2.5

589.43

679.73

e6/l

2.99

453

1037

Malignant neoplasm, wide definition for exclusion

765

1343

3.37

175.58

3.2

2.3

559.08

819.02

e6/l

8.71

743

1304

COPD/asthma related infections

813

1229

3.34

173.50

2.7

2.4

701.86

689.09

e6/l

0.21

784

1194

COPD/asthma/ILD related infections

813

1229

3.34

173.50

2.7

2.4

701.86

689.09

e6/l

0.21

784

1194

Medical observation and evaluation for suspected diseases and conditions

556

644

4.46

172.93

3.2

2.2

666.22

650.88

e6/l

0.24

538

615

Examination and observation for other reasons

505

642

4.60

171.79

2.6

2.2

743.00

651.66

e6/l

1.64

495

613

ILD medications: azathioprine

220

267

8.47

168.23

2.3

2.2

642.17

724.38

e6/l

1.14

210

260

Viral infections characterized by skin and mucous membrane lesions

489

1246

3.99

168.17

2.8

2.7

659.18

702.08

e6/l

0.98

473

1209

Chronic lymphocytic leukaemia, helper endpoint

102

37.54

162.82

2.7

1.5

562.84

840.10

e6/l

1.77

Chronic lymphocytic leukaemia

102

37.54

162.82

2.7

1.5

562.84

840.10

e6/l

1.77

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

102

37.54

162.82

2.7

1.5

562.84

840.10

e6/l

1.77

Any event in cancer register

765

1479

3.07

152.39

3.2

2.4

539.45

789.44

e6/l

31.69

737

1439

Viral infections characterized by skin and mucous membrane lesions

756

2316

2.82

144.12

2.6

2.5

727.88

695.46

e6/l

0.20

729

2246

Oxycodone

388

845

4.21

139.99

2.6

624.53

623.01

e6/l

0.01

368

818

Dental caries

317

644

4.82

137.56

3.2

2.4

619.39

688.27

e6/l

1.37

307

619

L04AD Calcineurin inhibitors

221

341

6.76

137.18

3.5

2.6

496.65

750.35

e6/l

6.33

214

334

Azathioprine

220

346

6.53

133.53

2.3

2.8

642.17

706.23

e6/l

0.83

210

338

Zoster [herpes zoster]

232

389

6.11

132.01

3.1

2.4

614.25

660.39

e6/l

0.50

224

369

857

1649

2.70

131.32

2.6

2.4

705.55

699.03

e6/l

0.06

828

1592

Bacterial Sepsis

422

978

3.73

127.08

2.6

2.4

621.70

646.88

e6/l

0.24

401

944

Autoimmune diseases

872

1700

2.63

126.00

2.8

2.5

711.39

697.96

e6/l

0.15

846

1653

Certain infectious and parasitic diseases

494

665

3.75

123.94

2.7

2.4

687.91

731.17

e6/l

0.69

477

639

Viral Sepsis

238

438

5.54

122.70

2.6

2.4

637.86

684.53

e6/l

0.58

223

422

Implicit viral Sepsis

237

436

5.55

122.23

2.6

2.5

636.61

683.36

e6/l

0.58

222

420

Purpura and other haemorrhagic conditions

209

347

6.21

120.39

3.7

2.6

520.43

692.10

e6/l

3.63

201

336

Other medical care

418

1062

3.58

120.36

2.3

2.7

527.19

719.48

e6/l

3.35

404

1020

Bronchitis

833

2081

2.54

120.32

2.8

2.4

686.30

704.76

e6/l

0.26

801

2018

Persons with potential health hazards related to communicable diseases

423

1230

3.46

118.19

2.4

2.7

846.79

768.51

e6/l

0.30

417

1203

Bacterial pneumonia (organism specified)

411

1059

3.56

117.63

2.4

2.6

653.44

646.35

e6/l

0.09

390

1021

Acute upper respiratory infections of multiple and unspecified sites

619

1616

2.86

117.47

3.0

2.4

691.84

683.20

e6/l

0.16

593

1565

Coagulation defects, purpura and other haemorrhagic conditions

252

513

5.02

116.05

3.4

2.6

544.21

694.05

e6/l

3.99

242

495

Systemic connective tissue disorders

339

871

3.95

115.56

2.4

2.5

686.41

683.37

e6/l

0.03

321

833

Acute upper respiratory infections

782

1890

2.57

114.77

2.7

2.4

706.76

698.68

e6/l

0.09

757

1825

COPD differential diagnosis

549

846

3.27

114.21

2.9

2.5

708.44

694.95

e6/l

0.17

531

829

ILD differential diagnosis

549

846

3.27

114.21

2.9

2.5

708.44

694.95

e6/l

0.17

531

829

Excluding asthma or asthma-COPD overlap

549

849

3.26

113.62

2.8

2.5

708.86

695.93

e6/l

0.16

531

832

Other pulmonary diagnosis

547

849

3.25

112.60

2.8

2.5

705.87

695.93

e6/l

0.12

528

832

Used for control exclusion in common control thyroid runs

805

1592

2.57

111.58

2.8

2.5

701.14

700.03

e6/l

0.01

776

1552

Implicit viral Sepsis

286

669

4.34

110.64

2.6

2.4

639.32

679.45

e6/l

0.58

268

648

Acute sinusitis

452

1325

3.19

109.55

2.9

2.5

727.61

690.71

e6/l

0.60

440

1288

Caries of dentine

269

585

4.55

109.50

2.9

2.5

606.99

665.87

e6/l

1.04

261

562

General examination and investigation of persons without complaint and reported diagnosis

444

644

3.62

108.49

3.1

2.2

698.68

650.88

e6/l

0.93

431

615

Aplastic and other anaemias

391

1078

3.42

106.06

2.8

2.4

688.70

654.35

e6/l

0.10

368

1037

Mantle cell lymphoma, including Hilmo

44.78

104.67

4.1

1.8

427.00

797.31

e6/l

1.53

Symptoms and signs involving the skin and subcutaneous tissue

570

2076

2.71

104.52

2.8

2.5

688.62

699.82

e6/l

0.13

556

2001

Implicit bacterial Sepsis

349

855

3.66

103.46

2.7

2.5

618.94

633.76

e6/l

0.11

331

826

Mycoses

284

698

4.14

103.08

2.7

613.44

684.53

e6/l

1.45

274

674

Other special examinations and investigations of persons without complaint or reported diagnosis

442

644

3.50

101.74

2.9

2.2

727.33

650.88

e6/l

1.47

427

615

Other reaction to severe stress, and adjustment disorders

358

1054

3.44

99.75

3.2

2.7

721.54

719.65

e6/l

0.02

348

1033

ILD, hospital admission 2, with pulmonary infections

118

127

9.53

99.18

2.4

1.9

580.70

630.96

e6/l

0.41

108

121

Zoster [herpes zoster]

400

1245

3.20

98.77

2.8

2.4

724.97

676.56

e6/l

0.15

384

1195

Drug-induced neutropenia

129

158

8.51

98.34

3.9

2.0

421.76

719.25

e6/l

4.05

118

153

All influenza

252

587

4.36

98.10

2.7

707.71

686.94

e6/l

0.21

242

574

Implicit bacterial Sepsis

363

918

3.45

97.96

2.6

2.4

623.24

635.46

e6/l

0.09

345

885

Persons encountering health services for specific procedures and health care

820

2128

2.33

97.20

2.4

2.6

653.63

735.02

e6/l

1.97

786

2072

Asthma (only as main-diagnosis)

457

839

3.17

95.83

2.0

2.5

795.82

694.73

e6/l

2.34

441

822

Asthma (only as main-diagnosis), excluding more controls

449

807

3.20

95.09

2.0

2.6

801.22

702.05

e6/l

2.19

433

791

Asthma

490

839

3.08

94.69

2.1

2.5

775.03

694.73

e6/l

1.71

472

822

Asthma, excluding more controls

478

807

3.11

93.50

2.1

2.6

779.38

702.05

e6/l

1.55

460

791

Solid cancers, helper endpoint

569

1245

2.72

92.17

2.8

2.3

560.32

820.39

e6/l

8.03

546

1207

Other and unspecified anaemias

342

975

3.38

91.75

2.9

2.4

699.77

659.51

e6/l

0.10

319

936

Other anaemias

345

989

3.35

91.31

2.9

2.4

698.62

660.54

e6/l

0.10

322

950

Asthma (mode)

474

846

3.02

89.36

2.1

2.5

775.41

694.95

e6/l

1.68

459

829

Any reimbursement code in KELA

432

675

3.23

88.32

3.1

2.2

749.65

786.85

e6/l

0.50

423

664

Other and unspecified dermatitis

425

1488

2.88

88.17

2.6

704.70

706.23

e6/l

0.01

412

1435

Neoplasms

569

1132

2.68

86.94

3.2

2.4

642.36

817.02

e6/l

8.95

557

1111

ILD, hospital admissions 3, with pneumonia sepsis

107

122

9.01

86.12

2.4

1.9

589.26

725.54

e6/l

0.75

117

Dermatitis

476

1787

2.68

85.69

2.5

2.6

706.58

691.42

e6/l

0.16

462

1726

Bacterial pneumoniae

311

800

3.46

84.94

2.1

2.5

709.23

670.82

e6/l

0.59

293

776

Asthma-related pneumonia

321

987

3.28

83.21

2.0

2.6

754.84

654.49

e6/l

2.67

309

946

Headache

434

1233

2.83

82.72

2.4

818.54

716.81

e6/l

2.48

419

1203

Asthma-related pneumonia or sepsis

321

993

3.26

82.39

2.0

2.6

754.84

655.93

e6/l

2.60

309

952

Asthma, hospital admissions 3, pneumonia

321

993

3.26

82.39

2.0

2.6

754.84

655.93

e6/l

2.60

309

952

Mantle cell lymphoma

48.12

82.27

4.3

1.8

359.07

811.92

e6/l

1.36

Asthma, unspecified (mode)

330

757

3.31

80.48

2.2

2.5

740.31

692.78

e6/l

0.78

314

740

Asthma, unspecified (mode), excluding more controls

324

732

3.33

79.95

2.2

2.6

747.21

699.35

e6/l

0.77

308

716

Other acute lower respiratory infections

431

1546

2.68

77.09

2.6

2.7

699.75

688.01

e6/l

0.17

412

1499

Thrombocytopenia, unspecified

113

159

7.35

76.43

3.8

2.1

487.34

714.73

e6/l

2.44

105

153

Other bacterial intestinal infections

176

380

4.71

75.59

2.9

2.7

610.18

665.16

e6/l

0.54

165

366

Codes for special purposes

418

1575

2.67

75.15

2.3

2.6

683.56

700.73

e6/l

0.26

393

1530

Bacterial pneumonia, not elsewhere classified

283

741

3.39

75.12

2.0

2.5

708.28

667.60

e6/l

0.60

266

719

Provisional assignment of new diseases of uncertain etiology

417

1570

2.68

75.09

2.4

2.6

684.84

701.15

e6/l

0.25

392

1526

Dermatitis and eczema

781

2304

2.11

74.62

2.6

728.04

690.11

e6/l

0.59

757

2231

Implicit Sepsis

519

1601

2.46

74.12

2.4

2.6

644.69

711.33

e6/l

0.78

491

1552

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

704

2127

2.17

72.60

3.4

2.4

600.67

741.41

e6/l

4.70

680

2060

Covid-19 confirmed case

304

990

3.11

71.93

2.4

2.6

681.28

677.90

e6/l

0.04

290

959

Other disorders of lacrimal gland

289

916

3.19

71.63

3.1

2.6

743.01

669.75

e6/l

1.02

278

876

Persons encountering health services for examination and investigation

386

644

3.02

71.40

2.9

2.2

692.92

650.88

e6/l

0.57

371

615

Diseases of the skin and subcutaneous tissue

673

1503

2.26

71.23

2.7

2.6

703.60

709.53

e6/l

0.05

648

1459

Viral pneumonia

139

259

5.47

70.89

2.6

2.4

577.67

730.74

e6/l

1.98

129

251

Cough

324

1046

2.96

69.67

2.6

2.7

648.68

691.80

e6/l

0.81

310

1013

Asthma, hospital admission 2, infections

458

1836

2.46

69.28

2.0

2.7

805.32

664.81

e6/l

4.83

445

1779

Asthma-related infections

458

1836

2.46

69.28

2.0

2.7

805.32

664.81

e6/l

4.83

445

1779

Other sexually transmitted chlamydial diseases

112

176

6.57

68.33

2.2

2.9

779.04

751.03

e6/l

0.27

112

171

Other respiratory diseases principally affecting the interstitium

167

376

4.52

68.15

2.3

2.2

561.56

635.81

e6/l

0.87

154

358

Other systemic involvement of connective tissue (FG)

207

545

3.79

66.85

2.5

2.6

674.52

697.98

e6/l

0.24

194

524

Bacterial intestinal infections, IBD co-morbidities

175

415

4.28

66.80

2.9

2.6

612.92

646.78

e6/l

0.30

164

396

Acute bronchitis

326

1127

2.86

66.62

2.6

2.7

701.40

688.10

e6/l

0.17

311

1088

Infection due to other mycobacteria

23.62

65.53

2.8

1.8

1729.75

492.45

e6/l

0.67

Other viral diseases

340

1234

2.76

65.10

3.1

2.7

666.87

745.77

e6/l

1.82

334

1206

Intestinal infectious diseases

663

2415

2.09

65.05

2.6

682.94

706.02

e6/l

0.36

635

2347

All kidney diseases

679

2246

2.08

63.71

2.6

667.10

709.39

e6/l

0.66

646

2182

Herpesviral [herpes simplex] infections

136

274

5.07

63.61

2.8

2.6

715.82

727.59

e6/l

0.07

130

266

Other systemic involvement of connective tissue

223

651

3.47

63.21

2.5

2.6

670.10

698.02

e6/l

0.30

210

619

Malignant neoplasm of skin

278

598

3.21

63.00

2.4

2.1

609.84

817.57

e6/l

1.71

265

569

Renal failure

330

1057

2.78

62.63

2.4

2.5

608.19

629.66

e6/l

0.22

315

1010

Candidiasis

243

757

3.25

62.09

2.7

2.6

753.23

726.61

e6/l

0.26

233

732

Other viral diseases

285

973

2.96

61.85

3.3

2.7

660.21

755.32

e6/l

1.93

279

950

Polyarthropathies

509

1450

2.31

61.06

2.4

2.7

634.77

653.39

e6/l

0.30

482

1414

Disorders of lacrimal system

314

1139

2.78

60.85

2.9

2.6

742.90

711.63

e6/l

0.22

302

1090

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

122

234

5.34

60.42

6.8

2.1

436.89

712.03

e6/l

5.52

122

223

Reimbursement for rheumatic diseases

408

1687

2.43

60.14

2.0

2.7

678.05

710.17

e6/l

0.35

384

1634

Candidiasis

145

325

4.55

59.62

2.7

2.5

637.29

712.97

e6/l

0.82

140

312

Interstitial lung disease endpoints

143

318

4.58

59.36

2.4

2.1

563.89

642.84

e6/l

0.80

132

302

Interstitial lung disease

143

318

4.58

59.36

2.4

2.1

563.89

642.84

e6/l

0.80

132

302

Other interstitial pulmonary diseases

143

319

4.56

59.13

2.4

2.1

563.89

645.35

e6/l

0.84

132

304

Oedema, not elsewhere classified

207

594

3.47

58.74

2.6

2.3

677.56

690.69

e6/l

0.13

192

573

Implicit Sepsis

531

1773

2.20

58.66

2.5

646.70

717.94

e6/l

0.93

504

1721

Renal tubulo-interstitial diseases

581

2053

2.12

58.60

2.5

2.6

681.74

701.59

e6/l

0.19

550

1991

359

1411

2.55

58.54

2.0

2.8

853.19

688.92

e6/l

4.63

348

1367

ILD, hospital admissions

141

316

4.54

57.97

2.4

2.1

566.82

638.91

e6/l

0.69

130

300

Malaise and fatigue

299

851

2.85

57.95

2.2

2.4

707.25

717.85

e6/l

0.09

283

823

Herpesviral [herpes simplex] infections

212

634

3.39

57.92

2.6

2.9

766.47

753.71

e6/l

0.13

203

617

Other bacterial intestinal infections

194

553

3.55

57.12

3.0

2.6

621.51

695.41

e6/l

0.98

183

535

Enterocolitis due to Clostridium difficile

114

217

5.36

56.87

3.0

2.1

567.17

697.77

e6/l

1.20

104

206

Other malignant neoplasms of skin (=non-melanoma skin cancer)

238

508

3.23

54.73

2.4

2.0

600.48

817.11

e6/l

1.44

225

483

Common variable immunodeficiency

25.32

54.44

1.7

1.4

563.98

619.05

e6/l

0.21

Diarrhoea and gastroenteritis of presumed infectious origin

494

2072

2.16

54.44

2.5

2.6

690.88

694.78

e6/l

0.06

480

2017

Complications of medical and surgical care

486

2071

2.17

54.42

3.5

2.4

635.27

703.40

e6/l

1.25

464

1998

Other diseases of pleura

311

1030

2.67

54.42

2.5

572.65

638.42

e6/l

1.29

289

990

Donors of organs and tissues

16.42

54.26

3.8

1.9

335.60

614.58

e6/l

3.30

Other disorders of skin and subcutaneous tissue

455

1826

2.23

53.97

2.4

2.6

651.10

687.44

e6/l

0.48

440

1758

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

230

329

3.53

53.74

3.0

2.2

723.38

717.47

e6/l

0.04

224

321

All chronic kidney diseases

383

1306

2.42

53.72

2.4

2.6

635.36

653.27

e6/l

0.27

365

1258

Chronic sinusitis

316

1228

2.59

53.69

2.3

2.7

778.82

639.56

e6/l

4.84

304

1185

Infections of the skin and subcutaneous tissue

437

1961

2.22

52.59

2.5

2.7

650.93

687.49

e6/l

0.84

427

1899

Anxiety disorders, excluding more controls

559

1759

2.08

52.11

2.9

2.5

756.15

666.25

e6/l

1.84

542

1704

Diseases of the respiratory system

362

703

2.59

51.41

2.6

2.4

717.76

703.88

e6/l

0.13

347

690

Dyspnoea

582

2146

2.01

51.33

2.4

2.6

670.36

700.39

e6/l

0.44

561

2072

Abnormalities of breathing

583

1664

2.04

50.69

2.3

2.7

716.98

694.13

e6/l

0.37

561

1620

Neurotic, stress-related and somatoform disorders

602

2130

1.99

50.57

2.9

2.6

759.89

685.62

e6/l

1.65

585

2063

Chronic kidney disease

216

694

3.08

50.52

2.3

2.4

589.02

612.14

e6/l

0.26

205

661

Polyneuropathies and other disorders of the peripheral nervous system

184

551

3.38

50.28

3.2

2.5

707.98

626.29

e6/l

1.07

178

524

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

245

558

3.00

49.69

2.4

2.1

609.23

816.37

e6/l

1.52

232

531

Tramadol

493

1414

2.15

49.62

2.2

2.6

750.16

658.85

e6/l

2.04

468

1380

Diseases of the eye and adnexa

556

1338

2.09

49.24

3.1

2.4

773.35

659.62

e6/l

3.97

546

1304

Anxiety disorders

603

2149

1.97

49.05

2.9

2.6

761.71

686.17

e6/l

1.70

586

2080

Any death

404

1270

2.29

49.03

2.4

2.6

662.07

641.03

e6/l

0.06

387

1216

Metabolic disorders

623

1950

1.96

48.73

2.4

2.7

674.85

667.45

e6/l

0.11

594

1900

Disorders of eyelid, lacrimal system and orbit

547

2073

2.01

48.56

2.7

2.5

714.81

686.98

e6/l

0.30

532

1994

Pain, not elsewhere classified

186

574

3.27

48.32

2.2

2.6

796.18

748.58

e6/l

0.52

180

557

Localized swelling, mass and lump of skin and subcutaneous tissue

239

855

2.82

48.00

2.6

2.5

597.47

688.86

e6/l

2.00

232

819

Gout, FINNGEN

201

653

3.10

47.71

2.8

2.3

546.10

585.85

e6/l

0.54

191

628

Use of teriflunomide

16.04

47.45

2.9

2.1

882.50

817.76

e6/l

0.24

Complications of surgical and medical care, not elsewhere classified

627

2252

1.92

47.23

3.2

2.4

649.50

704.11

e6/l

1.01

600

2182

Heart failure, not strict

475

1533

2.12

46.92

2.3

2.6

602.21

690.57

e6/l

1.45

442

1485

Gastrointestinal diseases

389

822

2.38

46.67

2.7

2.6

719.76

713.71

e6/l

0.06

379

796

Condition for Implicit Sepsis (Organ dysfunction codes)

527

1848

2.02

46.64

2.5

629.41

720.06

e6/l

1.69

499

1798

Acute renal failure

165

487

3.43

46.15

2.4

2.3

571.31

590.08

e6/l

0.11

157

462

Opioids

597

1577

1.97

45.94

2.5

2.6

759.59

672.09

e6/l

2.58

574

1542

Neurological diseases

564

1407

2.02

45.92

3.1

2.4

802.85

631.77

e6/l

7.96

542

1372

Intestinal infectious diseases

724

2267

1.83

45.69

2.6

2.5

697.17

699.67

e6/l

0.03

695

2202

Osteopathies and chondropathies

370

1545

2.25

45.27

2.7

2.6

682.90

696.43

e6/l

0.12

353

1489

Other sexually transmitted chlamydial diseases

117

276

4.32

45.19

2.1

3.1

786.74

745.04

e6/l

0.51

117

269

Gout

201

587

3.04

44.86

2.8

2.5

546.10

597.37

e6/l

0.68

191

562

Early onset COPD, excluding more controls

124

307

4.07

44.71

1.8

2.2

804.88

628.82

e6/l

2.67

117

301

Diagnoses used for exclusion with ILD

194

650

3.02

43.96

2.2

2.6

577.48

661.75

e6/l

1.34

181

628

Nutritional anaemias

317

1304

2.36

43.84

2.5

609.11

688.07

e6/l

2.09

301

1257

Diarrhoea and gastroenteritis of presumed infectious origin

636

2261

1.86

43.70

2.5

2.6

720.27

696.98

e6/l

0.34

616

2197

Erysipelas

391

1370

2.19

43.31

2.3

2.5

643.80

681.06

e6/l

0.47

377

1328

Other diseases of intestines

675

2098

1.84

43.01

2.5

2.7

721.66

683.95

e6/l

0.88

650

2040

ILD, hospital admissions 1, main diag only

117

295

4.03

41.35

2.3

2.0

571.86

647.97

e6/l

0.67

109

280

Other and unspecified polyneuropathies, also in other diseases

152

459

3.35

41.09

3.0

2.4

734.59

608.53

e6/l

1.69

146

434

Mycoses

543

2516

1.89

40.99

2.6

682.66

700.08

e6/l

0.24

524

2439

Persons encountering health services in other circumstances, wide

725

2104

1.78

40.82

2.5

2.6

714.28

678.39

e6/l

0.53

697

2046

Pain in joint

384

1131

2.18

40.22

2.2

2.6

764.95

640.85

e6/l

4.71

376

1091

Erysipelas

304

1164

2.32

40.04

2.3

2.4

647.42

661.72

e6/l

0.12

290

1127

Iron deficiency anaemia

273

1133

2.39

39.15

2.4

2.5

624.80

696.14

e6/l

1.54

258

1091

Visual disturbances and blindness

339

1573

2.17

38.67

2.7

2.6

753.84

682.73

e6/l

1.84

333

1511

Condition for Implicit Sepsis (Organ dysfunction codes)

530

1942

1.89

38.55

2.5

641.10

723.38

e6/l

1.50

500

1895

Mood disorders, excluding more controls

573

1856

1.85

37.88

2.7

2.5

756.17

662.19

e6/l

2.12

553

1799

Finngen Rheumatological endpoints

596

1858

1.83

37.74

2.4

2.7

697.00

686.65

e6/l

0.15

569

1820

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

126

351

3.57

37.69

1.9

2.1

461.93

691.26

e6/l

5.86

121

338

Symptoms and signs involving the circulatory and respiratory systems

610

1671

1.84

37.69

2.6

2.7

720.45

694.05

e6/l

0.47

589

1627

Noninfective enteritis and colitis

327

1516

2.17

37.33

2.3

2.8

681.69

698.96

e6/l

0.24

315

1471

Diseases of oesophagus, stomach and duodenum

648

2197

1.77

37.18

2.3

2.7

701.38

692.30

e6/l

0.10

626

2125

Nausea and vomiting

197

718

2.71

36.66

2.7

2.6

731.64

704.19

e6/l

0.25

190

688

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

368

1780

2.05

36.32

3.7

2.3

614.23

698.86

e6/l

1.45

354

1719

Methotrexate

239

4.15

36.22

1.8

2.9

778.62

681.83

e6/l

0.65

229

Other and unspecified iron deficiency

219

872

2.53

35.63

2.5

652.73

708.82

e6/l

0.86

207

839

Codeine

531

1549

1.87

35.49

2.4

2.6

760.13

672.58

e6/l

2.33

504

1514

Sarcoidosis

113

312

3.67

35.16

2.4

2.6

512.10

673.45

e6/l

2.37

108

300

Seropositive rheumatoid arthritis

157

539

2.93

33.90

2.1

2.5

596.03

680.15

e6/l

1.33

147

516

Basal cell carcinoma

192

489

2.73

33.48

2.3

2.1

576.40

818.43

e6/l

1.62

181

467

Asthma (diagnoses ohter than nonallergic)

524

2457

1.78

32.53

2.1

2.7

779.42

682.07

e6/l

2.30

506

2379

Acute myeloid leukaemia, including Hilmo

48.07

32.51

6.0

1.0

380.82

875.56

e6/l

—

Acute myeloid leukaemia

48.07

32.51

6.0

1.0

380.82

875.56

e6/l

—

Acute myeloid leukaemia, helper endpoint

48.07

32.51

6.0

1.0

380.82

875.56

e6/l

—

Depression

577

2254

1.74

32.22

2.7

2.6

766.65

674.28

e6/l

2.55

558

2186

Visual disturbances

304

1461

2.09

31.83

2.8

2.6

761.13

679.80

e6/l

2.05

299

1401

Basal cell carcinoma, including avohilmo

197

521

2.62

31.69

2.3

2.1

578.62

818.58

e6/l

1.74

186

495

Pleural effusion

105

296

3.59

31.68

2.4

2.2

499.70

627.36

e6/l

1.61

281

Persons encountering health services for other counselling and medical advice, not elsewhere classified

653

2103

1.69

31.49

2.5

2.6

743.69

678.26

e6/l

1.16

628

2045

Mood [affective] disorders

608

2320

1.70

31.21

2.7

2.5

764.09

676.58

e6/l

2.37

586

2249

Mood disorders

608

2321

1.70

30.98

2.7

2.5

764.09

676.79

e6/l

2.36

586

2250

Pulmonary heart disease, diseases of pulmonary circulation

192

769

2.51

30.96

2.4

939.58

638.40

e6/l

0.57

181

731

Rheumatoid arthritis

199

722

2.49

30.73

2.1

2.6

630.58

653.14

e6/l

0.21

188

696

Other noninfective gastroenteritis and colitis

181

710

2.57

30.50

2.4

2.7

744.73

709.41

e6/l

0.34

172

686

Osteoporosis

150

497

2.84

30.37

2.9

2.2

628.61

679.41

e6/l

0.49

142

468

Symptoms and signs involving the urinary system

450

1891

1.82

29.92

3.0

2.5

713.98

693.07

e6/l

0.23

429

1829

Other disorders of fluid, electrolyte and acid-base balance

190

730

2.50

29.91

2.0

2.6

909.65

630.49

e6/l

0.52

177

700

Venous thromboembolism

304

1443

2.05

29.80

2.4

2.5

805.39

662.40

e6/l

0.39

286

1387

Other/unspecified rheumatoid arthritis

239

3.81

29.68

1.9

2.2

646.81

650.70

e6/l

0.02

227

Lung cancer and mesothelioma

206

3.85

29.58

2.1

2.0

479.88

573.29

e6/l

1.26

201

Other complications of surgical and medical care, not elsewhere classified

233

3.83

29.18

2.7

2.4

679.58

750.37

e6/l

0.44

225

Asthma, hospital admissions , main diagnosis only

487

2468

1.75

28.97

2.0

2.7

807.81

681.82

e6/l

3.29

471

2391

COPD (mode)

137

368

2.94

28.35

1.9

2.1

715.34

655.38

e6/l

0.50

131

358

Gastro-oesophageal reflux disease

392

1842

1.84

27.83

2.4

2.7

731.49

679.00

e6/l

0.70

383

1777

Haemorrhage from respiratory passages

196

746

2.38

27.66

2.6

2.5

854.37

632.89

e6/l

0.41

187

716

Cardiovascular diseases

407

1173

1.87

27.44

2.6

2.9

749.67

753.55

e6/l

0.04

398

1162

Pain in throat and chest

468

1594

1.77

27.05

2.5

2.7

697.41

678.17

e6/l

0.36

449

1550

Use of hypnotics and sedatives

612

2144

1.64

26.87

2.4

2.6

717.14

689.98

e6/l

0.36

582

2086

Sulfasalazine

157

616

2.57

26.53

2.2

2.9

679.59

688.24

e6/l

0.06

148

598

Viral warts

156

615

2.56

26.16

2.6

2.7

656.46

737.03

e6/l

1.16

151

598

Pulmonary embolism

171

704

2.45

26.09

2.5

964.13

649.22

e6/l

0.53

162

669

Parasetamol

436

1225

1.81

26.08

2.8

2.6

715.48

655.46

e6/l

1.18

424

1199

Pulmonary heart disease

171

705

2.44

26.02

2.5

964.13

652.16

e6/l

0.52

162

670

Other infectious diseases

168

4.17

25.73

3.4

2.1

558.13

709.18

e6/l

1.15

163

Care involving dialysis

191

3.94

25.51

2.5

2.7

574.19

722.17

e6/l

1.14

184

Other arthritis (FG)

187

810

2.32

25.48

2.2

2.8

1008.65

684.83

e6/l

0.63

176

789

Malignant neoplasm of bronchus and lung, including Hilmo

211

3.55

25.41

2.1

1.8

482.20

675.77

e6/l

3.61

199

Chronic lower respiratory diseases

692

2344

1.58

25.28

2.1

2.7

761.38

688.04

e6/l

1.60

664

2277

Other diseases of upper respiratory tract

606

1945

1.63

25.15

2.7

2.6

747.10

672.08

e6/l

1.47

588

1876

Seropositive rheumatoid arthritis, wide

157

633

2.50

25.11

2.1

2.5

596.03

677.90

e6/l

1.21

147

604

Substance use, excluding alcohol

149

587

2.56

25.05

2.3

2.7

793.54

706.44

e6/l

1.09

140

575

Other/unspecified seropositive rheumatoid arthritis

155

623

2.51

24.96

2.1

2.5

602.74

675.38

e6/l

1.00

145

594

Continuous positive airway pressure

147

477

2.62

24.91

2.4

2.6

782.23

680.72

e6/l

1.17

142

465

Malignant neoplasm of other connective and soft tissue

9.37

24.84

1.9

1.5

370.23

980.61

e6/l

3.38

All anxiety disorders

370

1616

1.82

24.74

2.7

2.6

819.23

686.52

e6/l

4.85

358

1575

Other specific joint derangements/joint disorders

444

1657

1.74

24.59

2.3

2.7

765.84

671.59

e6/l

2.93

435

1619

DVT of lower extremities and pulmonary embolism

228

1081

2.11

24.59

2.4

2.5

886.20

647.58

e6/l

0.53

215

1033

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

153

617

2.50

24.48

2.1

2.5

602.78

674.26

e6/l

0.97

143

589

Hypoplasia of dental enamel

6.44

24.20

4.8

2.4

528.12

859.51

e6/l

2.72

Disorders of sclera, cornea, iris and ciliary body

322

1746

1.85

23.90

2.7

2.6

787.26

660.21

e6/l

3.83

310

1689

Codeine or tramadol medication

621

2145

1.59

23.61

2.4

2.6

743.20

681.79

e6/l

1.08

589

2090

Other functional intestinal disorders

259

1213

1.99

23.54

2.7

718.77

680.17

e6/l

0.57

245

1172

Disorders of mineral metabolism

184

3.86

23.53

2.2

2.4

524.48

656.59

e6/l

1.37

179

Other specified/unspecified arthritis

168

722

2.34

23.37

2.2

2.8

1055.17

669.50

e6/l

0.70

159

697

Other anxiety disorders

277

1239

1.95

23.33

2.6

824.97

708.63

e6/l

2.96

268

1217

Noninfectious colitis NAS

102

343

3.01

23.25

3.0

2.8

730.79

701.04

e6/l

0.19

330

Persons encountering health services in other circumstances

237

1168

2.03

23.01

2.2

2.7

769.95

676.59

e6/l

1.62

227

1135

Molar incisor enamel hypoplasia, with caries

7.26

22.91

5.8

2.0

584.89

1037.51

e6/l

2.75

Rheumatoid arthritis, including avohilmo

211

1004

2.11

22.87

2.0

2.5

638.64

687.03

e6/l

0.57

199

959

Any mental disorder

608

1925

1.59

22.54

2.8

2.5

746.31

670.20

e6/l

1.54

585

1866

Symptoms and signs involving the digestive system and abdomen

567

1768

1.61

22.45

2.8

2.5

699.84

669.18

e6/l

0.65

546

1709

Cardiovascular diseases (excluding rheumatic etc)

407

1347

1.74

22.32

2.6

2.8

720.20

748.91

e6/l

0.39

398

1330

COPD, hospital admissions 3, with asthma pneumonia sepsis

150

527

2.45

22.30

1.9

2.3

769.80

581.81

e6/l

3.16

143

498

Low back pain

430

1830

1.69

22.21

2.5

2.6

750.97

691.79

e6/l

0.91

409

1778

Iridocyclitis

147

612

2.42

22.02

2.4

2.7

816.60

674.53

e6/l

1.96

139

591

Benzodiazepine use

553

2406

1.59

21.99

2.6

2.5

746.66

683.73

e6/l

1.09

519

2342

Anxiety (asthma-related co-morbidities)

361

1587

1.77

21.99

2.7

2.6

814.44

675.58

e6/l

5.20

349

1551

Disorders of other endocrine glands

264

1357

1.92

21.96

2.7

702.08

720.32

e6/l

0.21

255

1313

Inflammatory bowel disease

207

994

2.10

21.95

2.1

2.9

668.96

692.68

e6/l

0.26

202

964

Other (seronegative) rheumatoid arthritis, wide

113

418

2.73

21.62

2.0

2.7

659.72

689.61

e6/l

0.17

106

400

Pain (limb, back, neck, head abdominally)

412

1192

1.74

21.59

2.6

716.75

654.41

e6/l

1.06

399

1150

Depression or dysthymia

397

1262

1.74

21.52

2.7

2.5

744.45

646.08

e6/l

1.39

379

1227

Other disorders of urethra and urinary system

366

1520

1.74

21.10

2.4

2.5

727.70

667.28

e6/l

1.37

345

1468

Heart failure,strict

270

997

1.92

21.03

2.1

2.5

549.78

680.32

e6/l

1.52

247

957

Other or unspecified immunodeficiency

28.95

20.98

2.1

1.5

861.14

621.42

e6/l

0.80

Other infectious diseases

209

3.49

20.96

3.3

2.2

592.73

716.55

e6/l

0.89

202

Abdominal and pelvic pain

557

1768

1.59

20.78

2.8

2.5

684.21

669.18

e6/l

0.27

538

1709

Syncope and collapse

195

794

2.11

20.59

2.4

2.5

728.76

704.48

e6/l

0.13

181

768

Migraine

291

1287

1.84

20.53

2.4

2.7

952.13

683.49

e6/l

0.96

286

1260

Diaphragmatic hernia

194

936

2.08

20.35

2.4

2.5

679.09

637.41

e6/l

0.47

187

892

Diseases of middle ear and mastoid

341

1603

1.75

20.24

2.4

2.6

748.99

710.86

e6/l

0.50

336

1556

Cutaneous abscess, furuncle and carbuncle

169

782

2.18

19.79

2.2

2.8

654.55

708.94

e6/l

0.65

161

758

Viral pneumonia (unknown virus, not influenza)

193

3.53

19.79

2.4

2.3

640.08

760.35

e6/l

0.91

188

Lack of expected normal physiological development

6.19

19.31

3.7

2.1

924.80

1004.98

e6/l

0.22

COPD, hospital admission 2, with asthma infections

168

665

2.18

19.20

1.9

2.4

765.26

580.66

e6/l

3.67

160

633

5-aminosalicylic acid

123

506

2.45

18.98

2.0

3.1

700.77

683.99

e6/l

0.12

118

497

Other soft tissue disorders, not elsewhere classified

522

1965

1.56

18.88

2.4

2.6

753.49

695.83

e6/l

0.97

502

1909

Acute tubulo-interstitial nephritis

314

1560

1.74

18.72

2.5

2.6

710.81

726.55

e6/l

0.12

292

1510

Other diseases of urinary system

541

1969

1.55

18.71

2.9

2.5

711.88

669.96

e6/l

1.09

519

1908

Dorsalgia

548

1902

1.55

18.70

2.5

2.6

761.80

692.04

e6/l

1.28

526

1850

Diseases of the myoneural junction and muscle

282

2.97

18.68

2.6

2.5

655.49

654.20

e6/l

0.01

271

Lower back pain or/and sciatica

560

2408

1.52

18.50

2.4

2.6

757.32

679.62

e6/l

1.88

536

2335

Disorders of conjunctiva

457

2330

1.58

18.40

2.5

2.6

765.63

704.24

e6/l

0.94

445

2255

Dysphagia

138

607

2.29

18.32

2.3

2.4

720.78

628.38

e6/l

1.29

132

578

Other diseases of the respiratory system

116

473

2.47

18.27

2.5

2.4

647.07

633.00

e6/l

0.08

104

448

Other respiratory disorders and diseases

116

473

2.47

18.27

2.5

2.4

647.07

633.00

e6/l

0.08

104

448

Hypothyroidism, strict autoimmune

319

1205

1.75

18.24

2.4

641.96

703.23

e6/l

0.66

306

1168

Other or unspecified common variable immunodeficiency

25.79

18.20

2.0

1.4

634.52

516.67

e6/l

0.40

Pain in limb

447

1888

1.59

17.90

2.5

2.6

756.32

697.17

e6/l

0.92

431

1832

Diseases of liver

200

1027

1.96

17.72

2.3

2.7

663.35

660.77

e6/l

0.02

191

988

Conjunctivitis

418

2197

1.59

17.65

2.5

2.6

786.30

711.79

e6/l

1.14

411

2128

Abnormal findings on examination of blood, without diagnosis

257

1312

1.81

17.51

2.4

2.6

607.67

644.94

e6/l

0.56

246

1265

Symptoms and signs involving the nervous and musculoskeletal systems

313

1852

1.70

17.35

2.8

2.6

876.30

664.25

e6/l

4.86

302

1788

Other heart diseases

293

1094

1.76

17.06

2.5

3.0

618.02

724.78

e6/l

3.40

283

1079

Recurrent or chronic depression

237

902

1.86

16.79

3.0

2.6

798.32

628.08

e6/l

6.18

229

882

Atopic dermatitis

317

1545

1.69

16.74

2.5

2.7

812.50

717.68

e6/l

2.11

311

1509

Complications of procedures, not elsewhere classified

407

2134

1.58

16.71

2.3

2.4

722.17

703.77

e6/l

0.20

387

2065

Diseases of the musculoskeletal system and connective tissue

319

927

1.73

16.69

2.4

2.7

776.50

715.86

e6/l

0.76

309

911

Bleeding

431

1966

1.56

16.38

2.5

2.6

723.03

666.53

e6/l

0.20

409

1899

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

277

1565

1.73

16.35

2.2

2.7

739.93

626.03

e6/l

2.52

267

1510

Fissure and fistula of anal and rectal regions

138

640

2.17

16.17

2.4

2.8

630.72

659.28

e6/l

0.32

133

618

Genitourinary diseases

354

1071

1.66

16.04

3.1

2.5

699.11

668.70

e6/l

0.36

346

1044

Other pleural conditions

182

3.27

15.69

2.6

1.9

427.87

679.15

e6/l

2.50

175

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

254

902

1.78

15.59

2.5

3.0

628.60

703.17

e6/l

1.46

242

891

Diverticular disease of intestine

330

1276

1.66

15.57

2.2

2.6

695.60

623.88

e6/l

0.78

318

1226

Unspecified kidney failure

183

3.25

15.55

2.0

534.32

602.48

e6/l

0.52

173

Anterior Iridocyclitis

123

554

2.24

15.53

2.4

2.7

823.44

686.76

e6/l

1.54

116

537

Diseases of the ear and mastoid process

619

2147

1.45

15.42

2.3

2.6

723.33

703.23

e6/l

0.25

602

2077

Non-ischemic cardiomyopathy

160

638

2.03

15.16

2.2

2.5

559.30

618.63

e6/l

0.85

142

615

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

148

721

2.05

15.10

2.1

2.6

828.42

706.75

e6/l

2.16

137

707

Extracorporeal dialysis

162

3.39

15.08

3.0

2.2

576.26

738.99

e6/l

1.03

157

176

836

1.94

15.03

2.6

2.2

570.79

653.84

e6/l

0.60

163

792

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

33.88

15.01

1.3

1.4

507.53

586.00

e6/l

—

Heart failure, strict

276

1144

1.71

14.90

2.1

2.5

559.41

672.56

e6/l

1.43

253

1098

Disorders of ocular muscles, binocular movement, accommodation and refraction

264

1546

1.70

14.83

3.0

2.7

788.69

714.29

e6/l

1.26

253

1500

All-cause Heart Failure

272

1126

1.71

14.81

2.1

2.5

552.33

674.64

e6/l

1.60

249

1082

Asthma, including avohilmo

626

2466

1.43

14.75

2.1

2.7

769.01

685.61

e6/l

1.95

601

2395

Disorders of skin appendages

265

1570

1.69

14.69

2.3

2.7

729.98

693.15

e6/l

0.59

260

1518

Rash and other nonspecific skin eruption

227

2.94

14.64

3.0

2.4

702.74

682.84

e6/l

0.09

220

Seronegative rheumatoid arthritis

212

3.00

14.50

2.2

2.7

711.86

726.20

e6/l

0.05

202

Psychiatric diseases

523

1780

1.47

14.22

2.7

2.5

725.70

667.89

e6/l

0.91

501

1727

Diseases of the digestive system

235

1357

1.73

14.12

2.6

631.54

671.67

e6/l

0.59

224

1304

Acute and subacute iridocyclitis

113

512

2.22

14.11

2.3

2.7

815.55

677.40

e6/l

1.43

107

496

Iron deficiency anaemia secondary to blood loss (chronic)

346

2.50

14.06

1.9

2.5

559.44

646.20

e6/l

0.84

328

Disorders of lens

337

1315

1.60

14.03

2.5

2.6

651.91

628.68

e6/l

0.31

326

1263

Benign neoplasm: Colon

255

1453

1.68

13.74

2.4

2.5

662.90

657.86

e6/l

0.03

244

1385

Skin changes due to chronic exposure to nonionizing radiation

162

778

1.93

13.70

2.7

2.1

543.56

656.23

e6/l

0.87

150

737

Irritable bowel syndrome

142

711

2.01

13.65

2.2

2.8

781.36

701.15

e6/l

1.17

136

688

Benign neoplasm of colon, rectum, anus and anal canal

297

1600

1.62

13.55

2.3

2.5

647.58

655.25

e6/l

0.05

285

1530

Covid-19 suspected case

131

643

2.05

13.34

2.4

2.8

707.63

750.89

e6/l

0.39

118

632

Missing teeth due to accident, extraction or parodontitis

285

1665

1.62

13.21

2.6

2.5

645.04

672.84

e6/l

0.29

273

1595

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

17.85

13.19

4.2

1.9

496.30

976.92

e6/l

1.17

Chronic myeloid leukaemia, including Hilmo

17.61

13.15

4.1

2.0

559.95

678.50

e6/l

0.42

Disorders of choroid and retina

389

1830

1.51

12.95

2.3

2.6

680.26

663.08

e6/l

0.18

371

1760

Actinic keratosis

156

761

1.91

12.79

2.6

2.1

543.60

657.93

e6/l

0.86

144

721

Endocrine, nutritional and metabolic diseases

443

1510

1.49

12.74

2.6

2.7

759.33

689.67

e6/l

1.32

426

1482

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

274

2.61

12.68

1.8

2.1

601.00

692.94

e6/l

0.97

264

Episodal and paroxysmal disorders

577

2085

1.41

12.56

2.5

2.7

786.96

655.17

e6/l

5.42

555

2026

Cystitis

410

1636

1.49

12.39

2.8

2.5

768.37

681.73

e6/l

2.78

395

1582

Chlamydial lymphogranuloma (venereum)

54.70

12.27

1.6

3.0

737.71

618.00

e6/l

—

Early onset COPD

124

616

2.03

12.26

1.8

2.6

804.88

612.93

e6/l

3.06

117

589

Care involving use of rehabilitation procedures

303

1784

1.57

12.26

2.4

2.7

732.26

727.27

e6/l

0.04

286

1730

Abnormalities of heart beat

162

862

1.85

12.25

2.3

2.7

705.37

694.72

e6/l

0.10

154

832

Other/unspecified dorsalgia

190

1076

1.76

12.15

2.7

713.23

667.05

e6/l

0.59

182

1045

Other antidepressants

522

1878

1.43

12.12

2.5

743.42

659.26

e6/l

1.74

494

1829

Postprocedural disorders of nervous system

186

2.94

12.02

3.1

2.8

854.61

721.92

e6/l

1.08

181

Hypo-osmolality and hyponatraemia

365

2.33

11.95

2.4

2.7

1221.96

634.18

e6/l

0.47

348

Hepatomegaly and splenomegaly, not elsewhere classified

11.06

11.92

2.3

2.1

480.27

632.86

e6/l

0.78

Benign neoplasms

513

1992

1.42

11.90

2.5

2.6

704.29

679.81

e6/l

0.42

499

1929

Heart failure and antihypertensive medication

143

480

1.96

11.88

2.2

2.8

564.27

699.63

e6/l

0.65

127

463

Sequelae of external causes of morbidity and mortality

134

694

1.94

11.78

3.0

2.5

698.59

664.88

e6/l

0.23

123

666

Other dorsopathies, not elsewhere classified

518

1915

1.42

11.72

2.4

2.6

747.24

692.84

e6/l

0.89

498

1863

Other obstetric conditions, not elsewhere classified

166

572

1.85

11.68

2.0

2.7

839.48

862.32

e6/l

0.23

161

565

Hypertensive diseases (excluding secondary)

289

1056

1.59

11.68

2.0

2.9

752.28

719.21

e6/l

0.35

283

1042

Colonic or urogenital fistula

145

779

1.87

11.42

2.4

2.7

626.53

681.79

e6/l

0.76

140

748

Disorders of lipoprotein metabolism and other lipidaemias

384

1608

1.48

11.33

2.2

2.7

702.76

632.31

e6/l

1.30

370

1560

Arthropathies

483

1719

1.43

11.23

2.4

2.7

765.57

677.50

e6/l

2.17

467

1681

COPD

204

987

1.70

11.19

1.9

2.5

738.90

599.72

e6/l

2.93

195

943

Other chronic obstructive pulmonary disease

196

946

1.71

11.19

1.8

2.5

749.65

591.16

e6/l

3.46

187

904

Other headache syndromes

207

1241

1.67

11.13

2.2

2.7

865.36

655.05

e6/l

6.75

197

1202

Chronic apical periodontitis

557

2302

1.38

11.00

2.5

665.40

701.43

e6/l

0.62

533

2232

Other joint disorders

460

1701

1.43

10.91

2.4

2.7

757.30

676.09

e6/l

2.66

450

1663

Misadventures to patients during surgical and medical care

320

2.36

10.90

2.8

2.3

682.83

679.98

e6/l

0.01

308

Other heart diseases, wide

483

2107

1.40

10.72

2.5

2.7

649.23

728.80

e6/l

1.72

458

2060

Gingivitis and periodontal diseases

518

1921

1.39

10.65

2.6

2.5

692.09

694.87

e6/l

0.03

504

1855

Other local infections of skin and subcutaneous tissue

263

2.49

10.63

2.8

2.7

645.23

698.26

e6/l

0.38

254

Soft tissue disorders

534

1991

1.38

10.50

2.6

760.63

697.09

e6/l

1.16

516

1935

Diseases of arteries, arterioles and capillaries (FINNGEN)

128

460

1.93

10.48

2.1

3.0

734.59

639.16

e6/l

0.54

120

451

Keratitis

179

1054

1.71

10.38

2.9

2.7

770.60

672.38

e6/l

1.77

174

1015

Asthma/COPD (KELA code 203)

474

2334

1.39

10.34

2.1

2.7

786.64

687.78

e6/l

2.03

455

2267

Diseases of oral cavity, salivary glands and jaws

273

894

1.57

10.27

2.2

2.4

680.90

740.19

e6/l

0.39

265

861

Phlebitis and thrombophlebitis (not including DVT)

114

587

1.95

10.27

2.3

2.7

630.31

681.05

e6/l

0.48

106

568

Other symptoms and signs involving the nervous and musculoskeletal systems

208

1278

1.63

10.24

3.1

2.6

851.42

687.72

e6/l

3.89

202

1238

Hernia

459

2200

1.40

10.24

2.7

2.6

804.30

667.28

e6/l

0.66

444

2126

Melanocytic naevi

153

867

1.77

10.18

2.6

2.7

651.84

717.07

e6/l

1.01

148

841

Sequelae with surgical and medical care as external cause

101

500

2.03

10.17

3.2

2.6

666.40

648.72

e6/l

0.12

480

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

270

1766

1.53

10.11

2.4

2.5

695.68

666.49

e6/l

0.39

256

1703

Malignant neoplasm of eye and adnexa, including Hilmo

9.36

10.08

2.5

1.7

688.35

749.18

e6/l

0.14

Abnormal findings in secretions and smears from cervix uteri vagina vulva

214

994

1.63

10.07

2.7

2.5

714.85

788.47

e6/l

1.49

209

963

Volume depletion

183

2.75

10.00

1.9

2.4

604.49

642.29

e6/l

0.21

177

Other and unspecified local infections of skin and subcutaneous tissue

247

2.49

9.99

2.9

2.7

648.48

711.47

e6/l

0.45

238

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

463

2134

1.39

9.88

2.4

2.6

623.09

675.26

e6/l

1.40

440

2069

Obesity related asthma

173

1025

1.69

9.84

1.9

2.7

894.99

645.02

e6/l

3.60

168

989

Antihypertensive medication - note that there are other indications

346

1246

1.48

9.76

2.4

2.9

781.95

745.20

e6/l

0.30

340

1222

Haemorrhoids and perianal venous thrombosis

139

776

1.79

9.67

2.1

2.6

737.86

622.68

e6/l

0.82

128

742

Lung diseases due to external agents

300

2.31

9.65

1.8

2.2

659.50

653.22

e6/l

0.03

286

Malignant neoplasm of head and neck

112

3.24

9.56

2.0

1.7

637.19

713.38

e6/l

0.33

107

Substance abuse, excluding more controls

268

1507

1.52

9.52

2.3

2.5

774.66

627.40

e6/l

3.85

254

1462

Other disorders of eyelid

184

1064

1.65

9.46

2.4

727.33

662.32

e6/l

0.36

179

1011

Viral and other specified intestinal infections

121

640

1.85

9.34

2.5

2.9

756.19

753.35

e6/l

0.02

115

630

Nerve, nerve root and plexus disorders

508

2294

1.36

9.31

2.5

735.40

681.04

e6/l

1.00

487

2219

Inflammatory diseases of female pelvic organs

256

1229

1.53

9.31

2.3

2.5

797.22

785.68

e6/l

0.08

246

1188

Spondylopathies

372

1558

1.43

9.16

2.3

2.6

703.75

677.66

e6/l

0.26

352

1509

Viral and other specified intestinal infections

150

842

1.73

9.10

2.6

2.9

770.57

751.68

e6/l

0.15

143

827

Spirochaetal infections, other/unspecified

205

2.56

9.04

2.0

2.3

653.40

689.73

e6/l

0.20

196

Caries of enamel

449

2371

1.37

8.89

2.9

2.5

705.87

712.91

e6/l

0.08

440

2295

COPD, hospital admissions

195

1029

1.61

8.86

1.9

2.4

748.94

604.10

e6/l

2.91

186

981

Other cataract

200

947

1.60

8.84

2.6

2.5

644.00

615.96

e6/l

0.36

191

905

COPD, early/later onset

196

1033

1.60

8.83

1.8

2.4

749.65

602.58

e6/l

3.01

187

985

Somatoform disorder

400

2.06

8.67

2.1

2.7

836.66

716.80

e6/l

1.05

393

Diseases of salivary glands

154

917

1.69

8.67

2.6

751.11

684.61

e6/l

0.45

149

883

Paralytic ileus and intestinal obstruction

110

596

1.85

8.55

2.3

2.6

618.11

620.72

e6/l

0.02

105

571

Diseases of tongue

115

3.07

8.54

2.3

3.0

695.89

685.73

e6/l

0.04

108

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

148

880

1.69

8.39

2.1

2.8

828.42

756.48

e6/l

0.99

137

864

Irregular menses

205

1035

1.57

8.35

3.0

2.5

823.02

753.46

e6/l

1.22

195

1012

Exposure to other specified factors

378

2512

1.38

8.34

2.6

696.77

684.16

e6/l

0.20

361

2440

Epilepsy

164

1000

1.64

8.34

2.3

2.8

1019.59

670.37

e6/l

0.60

158

973

Symptoms and signs involving speech and voice

152

913

1.67

8.30

1.9

2.5

740.29

681.18

e6/l

0.74

146

872

Senile cataract

272

1124

1.49

8.28

2.3

2.6

634.56

614.04

e6/l

0.23

263

1074

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

256

1365

1.49

8.21

2.6

2.5

687.98

733.45

e6/l

0.85

251

1316

Other disorders of ear

441

2135

1.35

8.12

2.4

2.6

691.59

687.92

e6/l

0.03

429

2061

Temporomandibular joint disorders, including avohilmo

207

1331

1.54

8.01

2.1

2.7

796.71

736.55

e6/l

1.04

201

1294

Use of peginterferon beta-1a

11.75

7.98

2.9

2.2

831.79

939.92

e6/l

0.29

Hypertension, essential

386

1581

1.38

7.93

2.1

2.8

713.07

691.63

e6/l

0.19

372

1539

Other neurological diseases

320

1784

1.41

7.82

2.7

2.6

701.96

673.47

e6/l

0.31

310

1713

Injuries to the abdomen, lower back, lumbar spine and pelvis

179

1126

1.58

7.77

2.2

2.7

932.84

685.34

e6/l

0.41

166

1084

Polycystic ovarian syndrome, consortium definition

292

1199

1.45

7.72

2.6

2.4

819.25

779.27

e6/l

0.34

276

1164

Other diseases of hard tissues of teeth

256

890

1.49

7.70

2.3

2.4

623.67

733.89

e6/l

1.04

243

857

Fibromyalgia

204

2.42

7.65

1.5

2.9

985.57

769.32

e6/l

1.56

197

Intracranial trauma

252

1204

1.47

7.62

2.4

738.41

630.34

e6/l

2.77

241

1174

Retinal detachments and breaks

151

927

1.63

7.61

2.3

2.5

686.92

610.64

e6/l

1.10

145

890

Malignant neoplasm of eye and adnexa

10.43

7.61

1.9

2.1

789.79

590.57

e6/l

0.55

GI-bleeding

138

828

1.67

7.60

2.5

601.50

627.46

e6/l

0.22

129

791

Other intervertebral disc disorders

387

1704

1.37

7.56

2.4

2.6

729.64

685.18

e6/l

0.57

374

1653

Constipation

415

2132

1.35

7.56

2.3

2.6

676.06

698.83

e6/l

0.29

390

2068

Fracture of lumbar spine and pelvis

484

1.88

7.53

2.1

2.5

616.33

644.57

e6/l

0.21

460

Symptoms and signs involving cognition, perception, emotional state and behaviour

460

2369

1.33

7.43

2.3

2.6

723.21

688.65

e6/l

0.52

444

2292

Gout, unspecified

482

1.88

7.35

2.6

2.2

552.32

588.37

e6/l

0.29

462

Cerebrovascular diseases (FINNGEN)

150

648

1.64

7.32

2.3

3.0

721.47

673.20

e6/l

0.38

145

638

Heart failure and bmi 25plus

148

608

1.65

7.27

2.2

2.6

564.33

640.95

e6/l

0.96

132

583

Malignant cancer of tonsil and base of tongue, including Hilmo

4.35

7.24

2.0

1.5

547.17

725.81

e6/l

0.98

Rheumatism, unspecified

293

2.13

7.20

1.6

2.7

919.18

668.53

e6/l

2.36

280

Diseases of arteries, arterioles and capillaries

284

1481

1.42

7.11

1.9

2.5

718.91

653.42

e6/l

0.44

265

1428

Congenital malformations, deformations and chromosomal abnormalities

295

2010

1.40

7.11

2.5

2.6

726.02

711.36

e6/l

0.19

288

1953

Other diseases of the digestive system

137

837

1.64

7.07

2.5

2.6

590.13

636.97

e6/l

0.46

128

799

DVT of lower extremities

446

1.89

7.06

2.2

2.6

641.49

670.57

e6/l

0.17

427

Intestinal stricture

134

817

1.65

6.99

2.5

568.60

660.47

e6/l

1.50

129

776

Gout, idiopatic and unspecified

105

600

1.76

6.96

2.5

2.3

584.23

578.43

e6/l

0.04

579

Dental operations

276

988

1.44

6.95

2.6

2.3

620.41

702.50

e6/l

1.77

265

955

Meningitis, viral

9.95

6.92

1.3

918.46

715.86

e6/l

0.57

Biological medication for rheuma

550

1.79

6.92

1.8

2.8

836.71

718.62

e6/l

0.79

537

Behçet disease

18.13

6.88

3.6

1.7

908.70

583.33

e6/l

—

Papulosquamous disorders

179

1174

1.53

6.85

2.4

2.7

704.81

668.00

e6/l

0.42

171

1129

Disorders of gallbladder, biliary tract and pancreas

451

2165

1.32

6.85

2.6

656.33

693.84

e6/l

0.53

437

2089

Dorsopathies

498

1943

1.30

6.85

2.5

2.6

762.87

691.12

e6/l

1.31

478

1891

Personality disorders, excluding more controls

115

677

1.70

6.85

2.2

2.8

794.06

696.67

e6/l

1.30

108

665

Sciatica+with lumbago

233

1480

1.45

6.84

2.3

2.6

795.15

683.82

e6/l

1.70

225

1438

Hypertensive diseases

396

1668

1.34

6.79

2.1

2.8

728.68

704.38

e6/l

0.23

381

1626

Hypertension

395

1663

1.34

6.78

2.1

2.8

729.03

704.13

e6/l

0.24

380

1621

Exclusions for E4_PCOS_BROAD

101

576

1.76

6.75

2.5

2.7

689.82

719.99

e6/l

0.25

564

Dizziness and giddiness

338

1970

1.36

6.75

2.4

2.6

739.51

686.83

e6/l

0.78

327

1900

Valvular heart disease excluding rheumatic fever

213

1043

1.48

6.62

2.3

2.7

616.66

704.09

e6/l

0.56

199

1009

Non-rheumatic valve diseases

209

1020

1.48

6.58

2.3

2.7

622.07

699.15

e6/l

0.46

195

986

COPD related to multimorbidity

157

848

1.57

6.58

1.9

2.4

729.54

580.13

e6/l

2.76

149

806

Poisoning by narcotics and psychodysleptics [hallucinogens]

3.88

6.57

2.2

2.0

651.42

690.00

e6/l

0.13

Tumor necrosis factor alpha inhibitors

481

1.82

6.48

1.8

2.7

844.53

738.41

e6/l

0.59

469

Polymyalgia rheumatica

233

2.20

6.48

2.1

711.30

613.27

e6/l

0.40

220

Triptan medication for migraine, min. 3 purchases

257

1388

1.42

6.44

2.4

2.7

834.24

735.26

e6/l

2.22

248

1354

Periodontitis

442

2269

1.30

6.42

2.5

2.6

681.67

683.90

e6/l

0.02

426

2191

Fracture of femur

100

522

1.74

6.39

2.5

2.2

664.38

642.41

e6/l

0.15

494

Chronic periodontitis, including avohilmo

440

2266

1.30

6.36

2.5

2.6

679.54

684.73

e6/l

0.06

424

2188

Autoimmune hepatitis

11.33

6.34

1.4

2.6

668.73

390.50

e6/l

—

Fall on same level

566

2443

1.27

6.32

2.4

2.6

707.26

705.22

e6/l

0.02

548

2373

Gastroduodenal ulcer

101

587

1.72

6.28

1.9

2.4

637.00

601.27

e6/l

0.30

558

Unspecified haematuria

180

998

1.50

6.16

2.6

2.5

635.64

639.42

e6/l

0.04

171

961

Conductive and sensorineural hearing loss

347

1752

1.34

6.08

2.4

2.6

659.50

670.53

e6/l

0.09

335

1683

Malignant neoplasm of thymus

16.03

6.00

2.3

1.3

403.89

1082.17

e6/l

—

Unspecified fall

230

1607

1.41

5.96

2.2

2.7

761.94

683.52

e6/l

1.55

224

1552

Psoriasis

129

814

1.59

5.93

2.6

2.7

658.22

680.20

e6/l

0.20

121

783

Complications of internal orthopaedic prosthetic devices, implants and grafts

495

1.76

5.92

2.3

2.1

560.49

646.05

e6/l

1.01

464

Concussion

209

1185

1.44

5.90

2.5

2.4

773.99

628.66

e6/l

3.87

200

1155

Congenital malformations, deformations and chromosomal abnormalities

312

2144

1.34

5.87

2.5

2.6

726.50

704.27

e6/l

0.33

303

2086

In situ neoplasms

148

966

1.54

5.87

2.8

2.4

589.11

689.79

e6/l

1.88

137

920

Retention of urine

139

730

1.57

5.84

2.5

2.4

693.52

587.79

e6/l

1.56

126

702

COPD, hospital admissions 1, only main diagnosis

134

730

1.58

5.81

2.0

2.3

745.28

595.05

e6/l

2.35

127

697

Conduction disorders

125

634

1.60

5.77

2.1

2.6

596.03

655.61

e6/l

0.73

117

614

Gout, strict definition

426

1.82

5.77

2.3

2.2

575.89

587.67

e6/l

0.07

409

Exclusions for E4_PCOS_CONSORTIUM

322

1503

1.34

5.76

2.5

2.6

728.40

769.15

e6/l

0.46

309

1458

Benign neoplasm: Stomach

200

2.21

5.71

2.0

487.73

681.30

e6/l

2.10

187

Any event in hilmo or specialist outpatient

+∞

5.69

3.6

0.0

323.29

—

e6/l

—

Other chronic obstructive pulmonary disease, including avohilmo

219

1281

1.42

5.62

1.8

2.5

730.04

616.05

e6/l

2.30

210

1223

Ptosis of eyelid

221

2.14

5.62

2.4

2.1

682.94

589.33

e6/l

0.91

210

Injuries to the ankle and foot

340

2297

1.32

5.61

2.4

2.7

722.28

688.07

e6/l

0.70

332

2231

Hypothyroidism, other/unspecified

395

2004

1.30

5.59

2.4

2.6

656.34

711.33

e6/l

0.94

380

1940

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

8.68

5.59

4.0

1.2

590.09

787.08

e6/l

0.48

malignant neoplasm of male genital organs

335

1.73

5.59

2.6

2.1

559.60

662.34

e6/l

1.27

324

Spinal stenosis

203

1075

1.44

5.58

2.4

2.5

668.97

659.26

e6/l

0.06

194

1031

Malignant neoplasm of tonsil

6.63

5.58

1.6

1.7

581.46

789.85

e6/l

0.82

Malignant neoplasm of tonsil, including Hilmo

5.94

5.55

1.6

1.7

627.86

804.13

e6/l

0.72

Sensorineural hearing loss

321

1639

1.33

5.49

2.3

2.6

661.26

660.52

e6/l

0.01

310

1570

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

16.76

5.47

1.4

3.0

487.00

918.60

e6/l

—

Excessive, frequent and irregular menstruation

155

557

1.53

5.45

3.0

2.2

831.87

745.06

e6/l

1.25

149

543

Malignant neoplasm of oropharynx, including Hilmo

5.25

5.41

1.5

1.6

620.60

740.41

e6/l

0.49

Malignant neoplasm of oropharynx

6.30

5.41

1.6

581.46

797.90

e6/l

0.91

Injuries to the head

526

2592

1.25

5.40

2.3

2.6

724.02

699.46

e6/l

0.37

506

2516

Hypothyreosis and Thyroxine purchase for inclusion criteria

404

2061

1.29

5.40

2.4

2.6

658.89

712.53

e6/l

0.93

389

1995

Lumbar disc prolapse

286

1632

1.35

5.38

2.4

2.6

762.24

684.18

e6/l

1.07

277

1585

Cardiomyopathy

438

1.76

5.29

2.1

2.6

641.03

620.12

e6/l

0.10

425

Strabismus

132

860

1.54

5.27

2.8

723.55

742.65

e6/l

0.17

124

836

Routine general health check-up of defined subpopulation

5.06

5.26

4.5

1.7

335.47

684.07

e6/l

2.42

Psoriasis vulgaris

521

1.70

5.26

2.8

2.7

655.06

682.98

e6/l

0.22

506

Chronic periodontitis, complicated

237

1715

1.37

5.23

2.6

701.16

636.66

e6/l

1.04

226

1652

Malignant neoplasm of heart, mediastinum and pleura

7.48

5.17

2.8

1.8

367.09

921.20

e6/l

1.97

Other CVD (FINNGEN)

195

2.04

5.16

1.9

2.6

654.93

590.56

e6/l

0.33

188

Selective serotonin reuptake inhibitors

462

1910

1.26

5.15

2.6

2.5

747.71

657.29

e6/l

1.88

438

1861

Pure hypercholesterolaemia

298

1461

1.33

5.15

2.2

2.7

663.66

619.08

e6/l

0.76

280

1417

Nonischemic cardiomyopathy

243

2.03

5.12

2.4

518.27

593.65

e6/l

0.59

237

LSIL lesion of the cervix uteri, vagina or vulva

350

1.84

5.04

2.7

2.9

665.72

839.92

e6/l

2.29

342

Exposure to unspecified factor

465

2678

1.25

5.01

2.1

2.6

725.59

699.99

e6/l

0.36

441

2604

Migraine, single triptan purchase ok & required. ICD-code if available is included

358

1878

1.29

5.00

2.6

2.7

793.80

673.78

e6/l

4.72

348

1828

Triptan medication for migraine, single purchase ok

358

1878

1.29

5.00

2.6

2.7

793.80

673.78

e6/l

4.72

348

1828

Other and unspecified effects of external causes

133

882

1.51

4.98

2.2

2.9

828.32

732.50

e6/l

1.07

127

859

Atrial fibrillation and flutter

139

597

1.51

4.89

2.9

3.0

577.80

646.78

e6/l

0.99

133

587

Explicit fungal Sepsis

5.95

4.81

1.5

2.0

526.92

416.95

e6/l

0.38

Scleritis

5.31

4.80

2.0

1.6

884.38

654.36

e6/l

0.71

Persistent mood disorders

482

1.69

4.79

2.7

758.29

698.73

e6/l

0.47

467

Other retinal disorders

251

1456

1.35

4.77

2.4

2.6

655.27

672.27

e6/l

0.13

237

1395

Presence of other functional implants

218

1102

1.37

4.67

2.0

2.2

663.65

702.94

e6/l

0.28

204

1053

Spondylopathies in diseases classified elsewhere

5.12

4.66

2.6

2.2

391.62

516.38

e6/l

0.61

Malignant neoplasm of testis, including Hilmo

3.54

4.63

2.5

2.4

499.33

803.00

e6/l

1.95

Dentofacial anomalies [including malocclusion]

318

1977

1.29

4.62

2.4

2.7

734.06

704.98

e6/l

0.54

309

1924

Substance abuse

268

1913

1.32

4.58

2.3

2.6

774.66

654.62

e6/l

2.82

254

1857

Pain in thoracic spine

376

1.76

4.57

2.5

2.9

696.45

662.90

e6/l

0.18

367

Otitis externa, unspecified

305

1.85

4.51

2.6

2.8

761.43

699.67

e6/l

0.36

297

Poisoning by drugs, medicaments and biological substances

113

741

1.53

4.50

2.1

3.0

753.54

737.09

e6/l

0.14

106

727

Cardiomyopathies, Primary/intrinsic

291

1.86

4.49

2.5

2.4

574.52

649.60

e6/l

0.43

283

Malignant cancer of tonsil and base of tongue

4.44

4.45

1.6

556.43

768.03

e6/l

1.11

Diseases of male genital organs

275

1049

1.33

4.42

2.9

2.6

660.78

600.89

e6/l

0.77

269

1021

Diseases of pulp and periapical tissues and dental caries

290

1134

1.31

4.36

2.5

2.4

626.90

688.84

e6/l

1.29

280

1097

Excessive attrition of teeth

253

1925

1.32

4.34

2.4

2.7

733.34

689.42

e6/l

0.73

248

1863

Mental and behavioural disorders due to psychoactive substance use

273

1942

1.30

4.34

2.3

2.6

768.77

655.60

e6/l

2.61

259

1885

Biguanides

280

2207

0.77

4.30

2.3

2.6

719.25

686.35

e6/l

0.28

265

2141

Adalimumab

289

1.84

4.28

2.1

2.9

837.79

680.19

e6/l

0.94

283

Functional dyspepsia

106

696

1.53

4.22

2.1

2.6

797.62

669.71

e6/l

1.64

100

673

Otitis externa

101

657

1.54

4.21

2.5

2.7

791.48

704.58

e6/l

0.88

101

636

Other external causes of accidental injury

396

1583

1.25

4.20

2.4

2.7

746.70

682.88

e6/l

1.47

382

1542

Diabetes medication

331

2477

0.79

4.15

2.3

2.6

700.93

696.32

e6/l

0.04

314

2408

Disorders of vitreous body and globe

197

1396

1.36

4.15

2.5

696.17

658.13

e6/l

0.34

187

1336

Diseases of pulp and periapical tissues, including avohilmo

488

2068

1.22

4.15

2.5

2.6

711.23

704.03

e6/l

0.08

468

2009

Malignant neoplasm of prostate

303

1.64

4.13

2.6

2.0

569.99

650.27

e6/l

0.77

292

HSIL lesion of the vagina

4.70

4.08

1.7

633.75

792.50

e6/l

0.44

Cardiomyopathy (excluding other)

301

1.80

4.07

2.5

2.4

574.52

651.71

e6/l

0.45

292

Other (not insulin) diabetes medications

292

2212

0.78

4.06

2.3

2.6

712.62

689.58

e6/l

0.19

276

2145

Nonpyogenic thrombosis of intracranial venous system

5.13

4.03

1.4

2.1

402.91

527.55

e6/l

0.48

Accidents

394

1583

1.25

4.02

2.5

2.7

752.91

682.88

e6/l

1.69

380

1542

Dermatophytosis

262

2024

1.30

4.02

2.5

2.6

692.66

663.16

e6/l

0.40

251

1959

Other disorders of conjunctiva

311

1.78

3.96

2.1

2.4

589.65

618.78

e6/l

0.18

296

External causes of morbidity and mortality

309

1209

1.28

3.95

2.6

2.5

740.01

692.53

e6/l

0.74

299

1176

Disease of hard tissues of teeth, NOS

222

868

1.34

3.93

2.6

2.4

630.25

717.85

e6/l

0.73

213

837

Caries of dentine, including avohilmo

358

1456

1.26

3.93

2.5

668.53

682.68

e6/l

0.20

348

1407

Coxibs

120

424

1.49

3.90

2.1

2.9

841.79

570.94

e6/l

2.50

115

412

Tuberculosis of nervous system

13.33

3.86

2.0

2.4

1114.67

518.20

e6/l

—

Heart failure and coronary heart disease

165

844

1.39

3.84

1.9

2.4

549.35

593.35

e6/l

0.63

154

802

Malignant neoplasm of prostate, including Hilmo

321

1.60

3.84

2.8

2.1

539.82

642.25

e6/l

1.23

310

Non-selective monoamine reuptake inhibitors

145

995

1.41

3.83

2.1

2.6

797.90

673.30

e6/l

1.15

135

961

Disorders of the thyroid gland

408

2163

1.23

3.82

2.5

2.6

671.22

706.64

e6/l

0.53

394

2091

Malignant neoplasm of adrenal gland

9.10

3.81

4.9

2.0

757.14

697.50

e6/l

—

Chronic myeloid leukaemia

9.08

3.81

1.3

2.3

791.43

716.75

e6/l

—

Lupus nephritis

12.42

3.79

2.0

3.0

546.00

898.00

e6/l

—

Degeneration of macula and posterior pole

162

933

1.38

3.79

2.3

624.58

647.16

e6/l

0.12

153

886

Dental caries, including avohilmo

321

1298

1.27

3.76

2.5

2.4

645.66

682.98

e6/l

0.63

311

1253

Other CVD

422

1.64

3.76

1.9

2.2

615.39

625.48

e6/l

0.05

399

Malignant neoplasm of anus and anal canal, including Hilmo

6.76

3.68

1.8

506.38

869.83

e6/l

—

Lung transplant status

4.54

3.66

2.5

2.4

625.64

540.68

e6/l

0.19

Injury, poisoning and certain other consequences of external causes

254

980

1.30

3.66

2.4

2.6

723.32

696.07

e6/l

0.31

244

952

Diabetes, insulin treatment (Kela reimbursement)

317

2389

0.80

3.66

2.2

2.6

684.78

689.34

e6/l

0.04

302

2318

Lung transplantation

4.54

3.66

2.5

2.4

625.64

540.68

e6/l

0.19

Other disorders of bladder

283

1.77

3.63

2.5

2.3

606.30

608.62

e6/l

0.01

270

Malignant neoplasm of testis

3.55

3.62

2.6

2.5

527.86

783.08

e6/l

1.45

Other and unspecified disorders of vitreous body

153

1097

1.38

3.61

2.4

2.5

711.55

666.81

e6/l

0.33

146

1045

Other shoulder lesions

226

1.87

3.58

2.4

2.8

655.21

700.59

e6/l

0.24

220

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

7.94

3.58

1.3

2.3

627.57

556.78

e6/l

—

Disorders of vitreous body

187

1359

1.33

3.54

2.6

2.5

698.87

659.52

e6/l

0.35

178

1300

Malignant neoplasm of adrenal gland, including Hilmo

6.31

3.52

4.4

1.9

962.88

563.62

e6/l

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

342

1865

1.24

3.52

2.3

2.5

642.20

727.93

e6/l

1.65

329

1803

Colectomy operation

400

1.63

3.49

2.1

2.4

857.03

619.98

e6/l

0.64

379

Injuries to the hip and thigh

181

1230

1.33

3.47

2.6

2.5

676.97

649.29

e6/l

0.29

172

1178

Osteochondrodysplasia with defects of growth of tubular bones and spine

7.62

3.45

1.9

2.8

425.00

520.50

e6/l

—

Coxarthrosis [arthrosis of hip](FG)

193

1025

1.33

3.43

2.5

2.6

640.93

630.66

e6/l

0.10

185

993

Neuroendocrine tumor and carcinoma of small intestine

5.79

3.35

4.5

1.9

366.00

781.21

e6/l

—

Superficial injury of lower leg

104

718

1.45

3.33

2.0

2.9

749.88

697.13

e6/l

0.54

698

Disorders in reading

2.66

3.32

6.9

2.3

743.29

668.98

e6/l

0.24

Falls/tendency to fall

512

2158

1.19

3.32

2.4

2.6

739.71

684.42

e6/l

1.57

495

2102

Drug-induced systemic lupus erythematosus

4.88

3.27

2.0

1.8

592.33

547.11

e6/l

—

Acquired pure red cell aplasia [erythroblastopenia]

6.60

3.22

2.3

2.5

494.29

445.64

e6/l

—

Crystal arthropathies, rheuma endpoint

4.21

3.20

1.4

2.9

711.90

494.71

e6/l

—

Perforation of tympanic membrane

243

1.78

3.18

2.2

2.7

613.07

641.61

e6/l

0.19

234

Oxicams

368

1.48

3.17

2.3

2.8

705.51

555.92

e6/l

2.06

356

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

141

1038

1.36

3.15

2.4

2.7

684.87

708.27

e6/l

0.23

135

1005

Crossbite

266

1.71

3.15

3.4

2.8

818.43

682.61

e6/l

0.81

261

Dependence on enabling machines and devices, not elsewhere classified

3.30

3.15

1.5

2.3

754.85

716.25

e6/l

0.06

Dermatographic urticaria

152

1.98

3.09

3.0

2.6

911.90

693.95

e6/l

1.24

147

Brain glioblastoma and astrocytoma

4.05

3.09

2.0

1.6

466.80

787.56

e6/l

—

Motor disorders

105

2.22

3.08

2.7

3.2

1041.09

802.30

e6/l

0.73

105

LSIL lesion of the cervix uteri

283

1.70

3.07

3.2

2.9

592.02

831.08

e6/l

3.81

277

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

2.70

3.06

2.1

876.40

760.04

e6/l

0.36

Injuries to the thorax

182

1397

1.30

3.05

2.2

2.6

701.02

636.67

e6/l

0.88

176

1342

Progressive systemic sclerosis

6.03

3.05

2.9

1.8

635.00

357.58

e6/l

—

Implicit parasitic Sepsis

6.02

3.05

3.0

1.4

701.00

653.00

e6/l

—

Infectious mononucleosis

262

1.73

3.02

3.1

2.8

602.78

695.03

e6/l

0.95

254

Primary biliary cholangitis (PBC)

4.32

3.00

3.6

1.7

697.22

677.29

e6/l

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

307

2260

0.82

2.99

2.2

2.6

688.62

689.93

e6/l

0.01

292

2200

Idiopathic gout

211

1.81

2.99

2.5

2.3

641.97

605.76

e6/l

0.14

203

Status epilepticus

2.36

2.99

2.5

2.3

990.00

713.94

e6/l

0.45

Other crystal arthropathies

3.89

2.99

1.4

3.0

711.90

475.08

e6/l

—

Diseases of inner ear

203

1534

1.28

2.98

2.3

2.6

654.70

687.91

e6/l

0.32

195

1471

Type 1 diabetes, strict definition

351

0.42

2.95

2.3

3.0

593.40

741.54

e6/l

0.65

346

Discitis, unspecified

3.29

2.94

1.5

1.9

587.00

559.59

e6/l

0.10

Brain glioblastoma

4.76

2.93

2.3

1.8

452.63

738.47

e6/l

—

Carcinoma in situ of other and unspecified genital organs

3.48

2.91

2.3

1.7

564.18

749.97

e6/l

0.50

Hypotension

334

1.62

2.90

1.8

2.1

642.57

607.01

e6/l

0.17

317

Other disorders starting during childhood or adolescence

241

1.74

2.89

3.1

2.8

802.10

818.09

e6/l

0.06

235

STROKE

239

1294

1.26

2.87

2.4

2.8

669.18

649.69

e6/l

0.21

230

1259

Ovarian cyst

125

523

1.38

2.85

2.4

2.3

821.76

745.39

e6/l

0.79

119

509

Chondropathies

424

1.54

2.81

3.1

2.6

799.45

704.37

e6/l

0.76

413

Angina pectoris

135

1200

0.75

2.79

1.9

2.6

652.23

657.03

e6/l

0.02

126

1156

Tooth eruption problems

486

1.49

2.75

3.3

2.9

787.00

740.43

e6/l

0.35

477

Chalazion

263

1.68

2.72

2.5

2.6

570.98

670.45

e6/l

0.92

256

Chronic suppurative otitis media, including avohilmo

218

1.75

2.72

2.4

2.6

829.55

748.92

e6/l

0.35

212

CR(E)ST syndrome

3.49

2.70

1.8

1.9

1139.40

699.72

e6/l

—

Medicines for HER+ breast cancer

895

0.67

2.69

2.1

2.5

573.96

758.15

e6/l

1.84

859

Disorders of vestibular function (Vertigo)

168

1281

1.29

2.67

2.4

2.5

661.98

701.92

e6/l

0.34

161

1225

Pacemaker

105

728

1.38

2.66

2.1

2.2

492.82

588.11

e6/l

1.42

690

Congenital malformation syndromes predominantly affecting facial appearance

4.91

2.64

3.1

2.4

959.86

801.07

e6/l

—

Implicit parasitic Sepsis

4.79

2.62

3.0

1.5

701.00

659.93

e6/l

—

Collapsed vertebra, not elsewhere classified

4.75

2.61

3.3

1.7

368.14

375.13

e6/l

—

Acquired absence of limb

4.07

2.58

1.0

2.4

707.00

490.95

e6/l

—

Spondylosis

205

1331

1.26

2.57

2.6

678.50

672.31

e6/l

0.04

195

1285

Malignant neoplasm of anus and anal canal

7.31

2.56

2.0

2.1

485.00

882.57

e6/l

—

Hard cardiovascular diseases

367

1842

1.19

2.56

2.2

2.7

678.74

663.26

e6/l

0.17

349

1790

Inguinal hernia

258

1406

1.23

2.56

2.6

622.87

641.06

e6/l

0.16

248

1358

Malignant neoplasm of nasal cavity and sinuses

5.56

2.56

2.5

1.9

799.33

1052.73

e6/l

—

Oral lichen planus and hypothyroidism or thyroxine medication

3.26

2.52

3.7

1.8

671.50

719.19

e6/l

—

Arthrosis

288

1301

1.22

2.51

2.3

2.7

757.53

644.70

e6/l

1.82

273

1267

Injuries to the knee and lower leg

527

2536

1.15

2.51

2.4

2.6

705.96

694.34

e6/l

0.15

505

2463

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

250

1.66

2.50

3.4

2.8

791.10

805.10

e6/l

0.05

244

Social disorders starting during childhood or adolecense, excluding more controls

3.88

2.48

2.1

2.7

881.50

716.52

e6/l

—

Any prescribed medicine buy

5.06

2.47

2.3

3.1

561.14

689.38

e6/l

—

Dilated cardiomyopathy

302

1.60

2.46

2.6

2.5

576.88

596.06

e6/l

0.10

290

Other disorders of penis

327

1.57

2.42

2.0

2.6

705.82

602.82

e6/l

0.92

317

Personality disorders

115

860

1.34

2.41

2.2

2.9

794.06

747.77

e6/l

0.47

108

843

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

5.08

2.41

3.7

1.9

532.67

786.17

e6/l

—

Hypoplasia of dental enamel, prenatal

3.54

2.41

6.1

3.0

824.78

1302.57

e6/l

—

Personal history of medical treatment

3.69

2.37

1.6

2.5

435.13

606.73

e6/l

—

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

4.15

2.36

4.1

1.8

592.14

758.76

e6/l

—

Suicide or other Intentional self-harm

102

753

1.36

2.34

2.1

2.9

775.16

737.64

e6/l

0.34

738

Hernia of abdominal wall

181

1447

1.25

2.31

2.9

2.6

1019.57

645.66

e6/l

0.74

176

1393

Palindromic rheumatism

3.94

2.26

1.7

2.8

671.00

574.50

e6/l

—

Transport accidents

199

1384

1.24

2.26

2.3

2.7

708.34

669.13

e6/l

0.64

192

1350

Cholelithiasis, broad definition with cholecystitis

337

1923

1.18

2.25

2.6

674.94

692.76

e6/l

0.18

327

1851

Kela-code for severe mental illness

1210

0.73

2.25

2.1

2.8

667.71

696.03

e6/l

0.24

1178

Fracture of lower leg, including ankle

224

1819

1.22

2.25

2.6

2.7

725.90

690.65

e6/l

0.33

215

1764

Open wound of lower leg

390

1.49

2.24

2.1

2.7

587.54

650.11

e6/l

0.47

377

Gonarthrosis [arthrosis of knee](FG)

272

1313

1.21

2.24

2.6

2.7

699.36

658.44

e6/l

0.37

253

1280

Car occupant injured in other and unspecified transport accidents

539

1.41

2.23

2.2

2.7

711.01

724.95

e6/l

0.10

524

Paroxysmal tachycardia

562

1.37

2.23

2.4

3.1

593.49

696.23

e6/l

1.50

553

Malignant neoplasm of floor of mouth, including Hilmo

5.63

2.22

6.0

2.1

432.40

616.78

e6/l

—

Noninflammatory disorders of female genital tract

146

567

1.29

2.19

2.8

2.3

771.81

743.43

e6/l

0.28

140

553

Operations 2 for CAVS

614

1.38

2.19

2.2

489.52

584.10

e6/l

1.31

581

Calcific aortic valvular stenosis, diagnosis (helper)

614

1.38

2.19

2.2

489.52

584.10

e6/l

1.31

581

Internal derangement of knee

142

1107

1.28

2.16

2.4

2.7

783.69

642.71

e6/l

1.83

134

1076

Shigellosis

3.75

2.16

2.1

2.2

836.43

585.16

e6/l

—

Coxarthrosis

178

940

1.25

2.16

2.4

2.6

654.54

615.41

e6/l

0.47

170

910

Follicular adenocarcinoma of thyroid gland, including Hilmo

4.34

2.16

2.5

1.3

616.17

844.57

e6/l

—

Childhood allergy (age < 16)

440

1.41

2.12

2.3

3.0

856.49

818.31

e6/l

0.24

432

Calcific aortic valvular stenosis, operated

618

1.37

2.12

2.2

489.52

585.11

e6/l

1.34

585

Calcific aortic valvular stenosis

618

1.37

2.12

2.2

489.52

585.11

e6/l

1.34

585

Calcific aortic valvular stenosis, including rheumatic fever

618

1.37

2.10

2.2

489.52

583.23

e6/l

1.30

585

Medical abortion

223

992

1.22

2.09

2.5

807.79

750.12

e6/l

0.84

213

961

Chromomycosis and phaeomycotic abscess

5.13

2.09

2.6

2.0

470.40

600.50

e6/l

—

Carcinoma in situ of vagina

5.11

2.08

1.4

1.2

438.60

759.80

e6/l

—

Glucagon-like peptide-1 (GLP-1) analogues

962

0.72

2.07

2.2

2.7

728.05

643.47

e6/l

0.89

934

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

962

0.72

2.07

2.2

2.7

728.05

643.47

e6/l

0.89

934

Systemic sclerosis,strict definition

3.55

2.06

1.3

1.8

926.57

615.80

e6/l

—

Carcinoma in situ of vulva

4.06

2.05

2.3

1.6

680.17

746.13

e6/l

—

Maternal care for known or suspected abnormality of pelvic organs

495

0.67

2.03

2.4

2.7

889.86

821.14

e6/l

0.57

486

Other specified/unspecified hearing loss

170

1.71

2.00

3.1

1.9

599.38

642.56

e6/l

0.22

158

Other and unspecified primary disorders of muscles

3.02

1.95

2.9

2.6

558.25

576.04

e6/l

—

Contact with hypodermic needle

3.82

1.95

3.2

1.4

1033.17

840.06

e6/l

—

Poisoning by medicine

666

1.34

1.93

2.1

2.9

766.96

740.37

e6/l

0.19

654

Malignant neoplasm of oral cavity

2.46

1.93

2.8

1.8

721.64

803.16

e6/l

0.12

Aortic aneurysm

553

1.37

1.92

2.2

2.3

790.25

566.88

e6/l

0.71

530

Persistent delusional disorders

189

0.42

1.92

3.4

2.6

564.13

712.05

e6/l

—

184

Neurofibromatosis, type 1

3.24

1.89

1.6

1.8

499.29

578.23

e6/l

—

Personal history of allergy to drugs, medicaments and biological substances

3.22

1.88

1.4

2.0

1106.43

493.27

e6/l

—

Unspecified mental disorder

105

1354

0.77

1.88

2.0

2.8

723.60

697.14

e6/l

0.24

100

1316

Premenstrual syndrome

3.21

1.88

1.9

1.5

907.00

704.73

e6/l

—

Other abnormal uterine and vaginal bleeding

378

1.39

1.88

2.5

2.3

788.94

711.79

e6/l

0.51

366

Prolonged pregnancy

379

0.60

1.87

2.4

2.8

816.00

850.83

e6/l

0.13

373

Cholelithiasis

318

1884

1.16

1.87

2.6

689.30

694.79

e6/l

0.05

308

1815

Other extrapyramidal and movement disorders in other diseases

611

1.34

1.85

2.4

2.5

815.36

675.93

e6/l

1.51

584

Sleep apnoea

389

2199

1.15

1.83

2.2

2.6

763.68

657.59

e6/l

1.84

374

2127

Malignant neoplasm of gum, including Hilmo

4.21

1.83

1.4

1.8

1090.80

882.58

e6/l

—

Other condition

393

1.43

1.81

2.9

2.5

678.75

682.67

e6/l

0.02

379

Sleep disorders (combined)

486

2259

1.13

1.79

2.2

2.7

802.90

665.12

e6/l

3.55

465

2191

Speech therapy

710

1.31

1.79

2.3

2.6

672.15

676.99

e6/l

0.03

687

Femoral hernia, unilateral

2.35

1.78

3.6

2.1

586.73

641.66

e6/l

0.16

Inguinal hernia, unilateral

2.35

1.78

3.6

2.1

586.73

641.66

e6/l

0.16

Inguinal of femoral hernia, unilateral

2.35

1.78

3.6

2.1

586.73

641.66

e6/l

0.16

Other arrhythmias

249

1593

1.18

1.77

2.5

2.7

656.46

715.16

e6/l

0.72

237

1551

Personal history of other diseases and conditions

328

1.46

1.75

3.2

2.4

756.37

807.58

e6/l

0.23

323

Female infertility, cervical, vaginal, other or unspecified origin

454

1.32

1.74

2.5

2.3

769.55

753.14

e6/l

0.13

447

Other orthopaedic follow-up care

117

1.80

1.74

1.7

2.4

778.38

791.94

e6/l

0.04

112

Social disorders starting during childhood or adolescence

2.71

1.73

2.1

2.9

881.50

790.93

e6/l

—

Other strabismus

711

1.31

1.73

2.9

2.8

758.00

758.33

e6/l

0.00

692

Rheumatic fever with heart involvement

3.92

1.72

3.0

2.3

633.20

415.62

e6/l

—

Type 2 diabetes, definitions combined, including avohilmo

319

2140

0.87

1.72

2.3

2.6

741.25

687.89

e6/l

0.58

302

2080

Cerebrovascular diseases

276

1663

1.17

1.71

2.3

2.6

830.47

635.21

e6/l

0.54

264

1593

Orchitis and epididymitis

274

1.50

1.71

3.0

2.5

617.73

558.31

e6/l

0.48

263

Shoulder lesions

301

1573

1.16

1.69

2.3

2.6

683.67

672.45

e6/l

0.10

292

1520

Disorders of adult personality and behaviour

117

929

1.26

1.68

2.3

2.9

798.71

741.10

e6/l

0.65

111

912

Hydrocele

333

1.45

1.67

2.7

2.5

568.88

543.45

e6/l

0.18

319

Soft tissue disorders related to use, overuse and pressure

762

1.29

1.67

2.0

2.7

795.43

629.97

e6/l

1.87

731

Secondary malignant neoplasm of other and unspecified sites

3.18

1.66

1.2

1.6

562.67

946.84

e6/l

—

Cardiac arrhythmias

272

1519

1.16

1.64

2.7

675.51

688.50

e6/l

0.16

259

1490

Thiazolidinediones

265

0.53

1.63

1.3

2.4

453.43

569.49

e6/l

0.92

254

Female infertility

465

1.29

1.63

2.6

2.3

799.60

755.64

e6/l

0.39

456

Obesity due to excess calories

188

1575

1.20

1.63

2.4

2.7

873.65

683.26

e6/l

4.67

181

1529

Major coronary heart disease event

344

1815

1.14

1.62

2.2

2.7

653.60

679.70

e6/l

0.24

321

1762

Malignant neoplasm of base of tongue, including Hilmo

3.61

1.62

3.0

2.0

299.20

795.07

e6/l

—

Benign neoplasm: Vulva

2.52

1.60

2.5

1.6

719.13

753.03

e6/l

—

Other arthrosis

190

1102

1.20

1.58

1.8

2.7

766.56

633.19

e6/l

2.20

179

1071

Dementia, including avohilmo

772

0.77

1.58

2.4

2.1

663.88

650.72

e6/l

0.05

726

Right bundle-branch block

2.21

1.57

1.3

1.8

699.45

797.66

e6/l

0.17

Other appendicitis

231

1.52

1.56

2.5

983.91

724.22

e6/l

0.37

223

Left ventricular outflow tract obstruction (LVOTO), broad definition

339

1.42

1.54

2.8

2.9

539.35

693.49

e6/l

1.47

333

Diabetes mellitus

364

2407

0.88

1.53

2.4

2.6

730.53

696.48

e6/l

0.36

343

2345

Hyperplasia of prostate

147

682

1.23

1.53

2.7

2.5

588.18

551.83

e6/l

0.44

141

656

Disorders of phosphorus metabolism and phosphatases

3.40

1.53

3.0

2.4

317.20

569.60

e6/l

—

Malignant neoplasm of other and ill-defined sites, including Hilmo

2.87

1.51

2.0

1.6

306.00

918.19

e6/l

—

521

1.31

1.48

2.2

2.0

661.47

591.66

e6/l

0.40

486

Atrial fibrillation and flutter with reimbursement

445

1.29

1.48

2.6

2.8

560.11

611.07

e6/l

0.54

436

Ischemic heart diseases

344

1821

1.14

1.47

2.2

2.7

645.27

686.35

e6/l

0.42

325

1769

Fracture of shoulder and upper arm

130

1064

1.22

1.45

2.2

2.6

715.95

662.45

e6/l

0.60

123

1024

Injuries to the shoulder and upper arm

343

2445

1.13

1.44

2.2

2.7

705.81

679.58

e6/l

0.34

323

2372

Other acquired deformities of ankle and foot

3.16

1.44

1.8

1.9

727.60

653.94

e6/l

—

Pre-eclampsia or eclampsia

568

0.70

1.44

2.5

2.8

848.42

803.83

e6/l

0.22

551

Hypertensive heart and/or renal disease

500

1.29

1.43

1.8

2.5

661.15

582.13

e6/l

0.69

476

Supervision of high-risk pregnancy

333

1.32

1.43

1.9

2.7

894.16

839.59

e6/l

0.46

323

Hypoplasia of dental enamel, prenatal , including avohilmo

2.25

1.43

5.7

3.2

846.40

1035.41

e6/l

—

Lesion of lateral popliteal nerve

118

1.70

1.41

2.6

2.5

934.50

709.19

e6/l

0.63

113

Ulcerative rectosigmoiditis

229

1.49

1.41

2.2

2.9

709.91

694.30

e6/l

0.05

223

Open wound of head

221

1835

1.16

1.40

2.2

2.7

694.94

652.79

e6/l

0.62

214

1775

Injuries to the wrist and hand

427

2653

1.12

1.40

2.4

2.6

699.63

694.03

e6/l

0.07

418

2566

Percutaneous Coronary Intervention

322

1740

1.13

1.39

2.2

2.7

658.05

684.89

e6/l

0.23

303

1690

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

527

1.31

1.39

2.2

2.7

752.61

759.87

e6/l

0.04

518

Anosmia

2.66

1.39

1.2

2.3

827.33

790.55

e6/l

—

Adjustment and management of implanted device

355

1.38

1.39

1.6

2.4

604.45

647.10

e6/l

0.23

332

Congenital dislocation of hip, unilateral

2.65

1.37

3.5

2.4

1028.67

987.04

e6/l

—

Seminoma of testis

2.64

1.37

3.7

2.4

506.83

727.17

e6/l

—

Urticaria due to cold and heat

2.64

1.37

2.2

2.1

637.83

708.70

e6/l

—

Superficial injury of ankle and foot

373

1.37

2.6

2.7

811.29

712.01

e6/l

0.74

365

Superficial injury of abdomen, lower back and pelvis

399

1.36

2.1

2.5

764.92

699.08

e6/l

0.37

386

Peripheral artery disease

134

881

1.21

1.36

1.7

2.4

677.62

586.00

e6/l

0.58

125

843

Cluster headache, strict

1.76

1.35

1.2

2.7

919.82

685.05

e6/l

0.98

Diabetes, varying definitions

365

2397

0.89

1.35

2.4

2.6

724.19

696.25

e6/l

0.28

344

2335

Other/unspecified enthesopathies, not elsewhere classified

191

1.52

1.34

1.7

2.7

893.14

663.71

e6/l

1.13

184

Complications associated with artificial fertilization

2.16

1.34

2.1

752.67

743.02

e6/l

—

Carpal tunnel syndrome

221

1685

1.16

1.33

2.3

2.6

753.90

683.80

e6/l

0.92

211

1627

Other otitis externa (chronic)

160

1.57

1.31

2.4

846.76

679.32

e6/l

0.81

154

Cluster headache, wide

106

1.71

1.29

1.2

2.7

973.67

679.21

e6/l

1.30

106

Lichen planus

284

1.41

1.29

1.9

2.5

816.57

678.67

e6/l

0.64

271

Valgus deformity, not elsewhere classified

2.81

1.29

5.6

1.6

754.40

472.72

e6/l

—

Thoracic aortic aneurysm

369

1.36

1.29

2.0

2.4

951.38

578.21

e6/l

0.82

353

Malignant neoplasm of rectosigmoid junction

2.79

1.28

2.4

1.7

670.40

822.89

e6/l

—

Secondary malignant neoplasm of respiratory and digestive organs

2.79

1.28

1.6

490.00

882.44

e6/l

—

Traumatic subarachnoid haemorrhage

1.89

1.28

3.2

2.3

567.08

546.39

e6/l

0.10

Outcome of delivery

280

0.68

1.28

1.9

2.7

872.74

883.77

e6/l

0.04

271

Coronary revascularization (ANGIO or CABG)

320

1740

1.13

1.26

2.2

2.7

661.92

684.89

e6/l

0.19

301

1690

L02BG Aromatase inhibitors

711

0.76

1.25

2.2

2.5

541.47

745.53

e6/l

1.78

678

Seminoma of testis, including Hilmo

2.42

1.25

3.7

2.4

506.83

723.76

e6/l

—

Isolated growth hormone deficiency

2.01

1.24

2.2

4.0

746.82

617.93

e6/l

0.43

Atrioventricular septal defect

2.69

1.22

1.6

4.4

212.80

472.63

e6/l

—

Tarsal tunnel syndrome

2.65

1.22

4.2

2.5

477.20

545.32

e6/l

—

Gonarthrosis

232

1152

1.15

1.22

2.5

2.7

689.19

640.32

e6/l

0.42

214

1119

Presence of cardiac and vascular implants and grafts

141

881

1.19

1.21

1.8

2.2

534.33

631.61

e6/l

1.62

132

840

Acetic acid derivatives and related substances

415

1.24

1.20

2.1

2.8

827.68

571.27

e6/l

1.82

403

Primary hyperparathyroidism

214

1.45

1.18

2.5

2.3

663.10

674.23

e6/l

0.04

204

Specific personality disorders

740

1.23

1.15

2.2

2.9

839.94

755.88

e6/l

0.84

725

Type 2 diabetes, strict (exclude DM1)

326

2133

0.90

1.15

2.3

2.6

723.50

686.61

e6/l

0.36

308

2071

Hypertensive Heart Disease

459

1.26

1.14

1.6

2.5

625.75

573.93

e6/l

0.35

436

Diseases of appendix

301

2426

1.12

1.14

2.5

2.6

699.03

674.45

e6/l

0.22

293

2352

Type 2 diabetes

343

2225

0.90

1.13

2.4

2.6

742.04

690.56

e6/l

0.58

324

2163

Disorder of lipoprotein metabolism, unspecified

275

1.38

1.13

1.8

2.5

914.85

585.34

e6/l

0.61

264

Hyphaema and other vascular disorders of iris and ciliary body

2.01

1.12

3.8

2.1

690.00

585.03

e6/l

—

Malignant neoplasm of tongue, including Hilmo

2.01

1.12

2.4

1.6

330.38

822.38

e6/l

—

Type 2 diabetes, definitions combined

325

2120

0.90

1.10

2.3

2.6

727.15

687.05

e6/l

0.40

307

2060

Appendectomy

258

2195

1.12

1.09

2.3

2.6

729.70

682.43

e6/l

0.42

249

2132

Statin medication

248

1573

0.89

1.09

2.4

2.8

722.70

675.20

e6/l

0.49

243

1531

Congenital stenosis of pulmonary valve

2.15

1.06

2.0

2.3

638.43

640.09

e6/l

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

105

1.62

1.06

2.9

1.9

863.59

683.19

e6/l

0.40

100

Emergency coronary revascularization (for ACS)

336

1843

1.11

1.05

2.2

2.7

651.72

677.02

e6/l

0.23

316

1785

Oligomenorrhoea

1.71

1.05

5.4

2.2

671.21

776.98

e6/l

0.33

Contact with other sharp object(s)

204

0.59

1.05

1.5

2.7

629.92

691.87

e6/l

0.26

199

Right ventricular outflow tract obstruction

1.99

1.04

1.8

2.7

396.56

884.09

e6/l

—

Appendicitis, broad definition

296

2408

1.11

1.04

2.5

2.6

699.97

674.45

e6/l

0.23

288

2335

Insulin, intermediate and long-acting

160

1791

0.87

1.04

2.1

2.7

606.32

657.43

e6/l

0.69

154

1726

Epidural haemorrhage

2.29

1.03

2.0

1.9

803.40

499.68

e6/l

—

Pre-eclampsia

521

0.75

1.03

2.5

2.9

850.25

808.65

e6/l

0.20

507

Diabetic retinopathy

465

1.22

1.03

2.3

657.13

679.54

e6/l

0.14

436

Polypectomy (DHB20)

178

0.56

1.03

1.3

2.3

801.90

681.16

e6/l

—

172

Decubitus ulcer and pressure area

106

1.61

1.02

2.5

1.9

754.82

703.33

e6/l

0.13

100

Non-small cell lung cancer, adenocarcinoma, helper endpoint

114

1.58

1.02

1.6

2.1

429.00

660.36

e6/l

1.50

108

Stenosis and insufficiency of lacrimal passages

180

1.45

1.00

2.4

2.3

646.81

618.23

e6/l

0.10

173

Embedded teeth, including avohilmo

282

1.35

1.00

2.4

2.8

814.24

743.76

e6/l

0.36

275

Autoimmune hyperthyroidism

1.63

0.97

2.7

2.3

795.40

740.13

e6/l

0.16

Loose body in joint

1.81

0.96

4.9

2.3

545.00

592.38

e6/l

—

Dementia due to Parkinsons disease, excluding more controls

0.00

0.96

0.0

2.1

—

468.55

—

Infection of intervertebral disc (pyogenic)

2.24

0.93

2.2

2.1

608.00

448.48

e6/l

—

Palatinal maxillary operation

2.16

0.92

1.3

2.0

642.83

649.89

e6/l

—

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

2.15

0.91

1.3

1.8

369.33

824.04

e6/l

—

Intracranial injury

220

1859

1.12

0.91

2.3

2.7

746.59

662.81

e6/l

1.81

211

1801

Obstructed labour due to maternal pelvic abnormality

348

0.72

0.89

2.3

2.6

706.20

758.23

e6/l

0.27

334

Postviral fatigue syndrome

2.02

0.87

1.2

1.9

942.33

766.40

e6/l

—

Family history of other specific disorders

2.01

0.87

1.7

1.6

1179.50

700.83

e6/l

—

Other congenital malformations of ear

1.79

0.84

2.4

2.8

667.25

669.82

e6/l

—

Brachial plexus disorders

256

1.33

0.84

1.7

2.7

803.62

764.48

e6/l

0.17

250

Other disorders of iris and ciliary body

1.76

0.83

3.3

2.0

697.30

613.49

e6/l

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

520

1.18

0.83

2.7

2.3

631.86

926.20

e6/l

2.17

497

Malignant neoplasm of breast, including Hilmo

520

1.18

0.83

2.7

2.3

631.86

926.20

e6/l

2.17

497

1.73

0.80

2.2

2.6

1152.70

779.22

e6/l

—

Aortic valve malfunction, age under 60 years

303

1.29

0.79

2.9

2.6

555.92

677.25

e6/l

0.85

297

Osteomalacia

0.00

0.79

0.0

1.8

—

607.35

—

Acute appendicitis

273

2332

1.09

0.77

2.5

2.6

652.63

676.80

e6/l

0.38

265

2262

Other nutritional deficiencies

255

2189

1.10

0.76

2.4

2.6

837.84

678.69

e6/l

4.55

244

2124

Type 2 diabetes, wide definition

304

1786

1.09

0.75

2.3

2.6

716.22

670.81

e6/l

0.41

289

1731

Phakomatoses, not elsewhere classified

1.81

0.73

1.6

2.2

499.29

529.67

e6/l

—

malignant neoplasm of female genital organs

175

1.36

0.72

1.8

2.3

588.21

778.88

e6/l

1.18

164

Multiple delivery

230

0.69

0.72

2.5

2.9

673.88

801.68

e6/l

0.59

225

Malignant neoplasm of breast

515

1.17

0.71

2.8

2.3

629.99

928.33

e6/l

2.17

492

Delayed puberty

1.94

0.71

1.2

2.7

725.40

638.81

e6/l

—

Stroke, excluding SAH

197

1300

1.11

0.70

2.1

2.5

906.90

629.18

e6/l

0.56

189

1243

Insulin medication

200

1853

0.91

0.69

2.2

2.7

603.01

658.26

e6/l

0.91

193

1796

Malignant neoplasm of breast, HER2-negative

506

1.16

0.69

2.6

2.3

612.65

928.04

e6/l

2.34

483

Sequelae of intentional self-harm, assault and events of undetermined intent

1.87

0.69

1.0

2.1

1005.20

655.85

e6/l

—

Gilbert syndrome

1.87

0.69

2.4

1.9

563.00

639.56

e6/l

—

Myocardial infarction, strict

128

1029

0.88

0.68

1.9

2.6

654.64

603.00

e6/l

0.26

117

988

Polyp of the female genital tract

439

1.17

0.68

2.3

758.06

707.19

e6/l

0.46

427

Other symptoms and signs involving cognitive functions and awareness

147

1197

1.12

0.66

2.0

2.5

696.92

635.24

e6/l

0.63

140

1144

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

1.79

0.66

1.6

1.5

706.80

793.54

e6/l

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

179

0.67

0.66

2.5

2.6

833.00

737.63

e6/l

0.31

171

Behavioural syndromes associated with physiological disturbances and physical factors

370

2446

1.07

0.66

2.2

2.6

795.19

687.76

e6/l

2.65

355

2373

Intrahepatic Cholestasis of Pregnancy (ICP)

178

0.67

0.64

1.8

2.8

980.17

811.83

e6/l

0.85

173

Extrapyramidal and movement disorders

116

1026

1.13

0.64

2.5

775.73

643.87

e6/l

2.10

108

981

Medial epicondylitis

1.48

0.64

2.0

2.3

736.50

628.71

e6/l

0.39

Lichen planus, including avohilmo

468

1.20

0.64

2.4

2.5

813.46

678.70

e6/l

0.85

449

Diffuse brain injury

1.52

0.62

2.0

2.6

802.08

560.16

e6/l

0.95

Pregnancy with abortive outcome

210

999

1.10

0.62

2.6

2.5

808.63

749.25

e6/l

0.87

199

967

Complications of labour and delivery

168

1033

0.90

0.62

2.8

2.4

745.40

801.68

e6/l

0.43

162

994

Ankyloglossia

1.52

0.62

5.9

2.8

847.83

826.57

e6/l

0.04

Atherosclerosis, excluding cerebral and coronary sclerosis

114

799

1.13

0.61

1.7

2.4

707.91

575.77

e6/l

0.76

106

763

Sleep apnoea, including avohilmo

392

2274

1.07

0.61

2.2

2.6

772.58

662.00

e6/l

2.00

376

2202

Degenerative myopia

0.00

0.60

0.0

1.8

—

530.50

—

Carcinoma in situ of breast, other/unspecified

0.00

0.60

0.0

1.6

—

527.90

—

Effects of air pressure and water pressure

0.00

0.60

0.0

2.2

—

567.71

—

Injuries to the elbow and forearm

267

2174

1.08

0.60

2.3

2.7

710.37

707.39

e6/l

0.02

259

2106

Other congenital malformations of skull and face bones

0.00

0.60

0.0

3.6

—

860.64

—

Pre-eclampsia or poor fetal growth

820

0.86

0.59

2.6

880.30

807.16

e6/l

0.53

800

Artrosis, including avohilmo

306

1799

0.93

0.59

2.2

2.7

761.66

650.69

e6/l

1.97

292

1752

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

117

1140

0.89

0.59

2.3

2.6

866.46

758.94

e6/l

1.52

109

1108

Radial styloid tenosynovitis [de Quervain]

131

1.38

0.59

1.3

2.7

989.78

704.14

e6/l

1.51

126

Single delivery by forceps and vacuum extractor

301

0.82

0.58

3.1

2.8

863.98

890.29

e6/l

0.13

293

Primary gonarthrosis, bilateral

133

1265

0.90

0.58

2.2

2.5

564.27

650.59

e6/l

0.95

124

1211

Abnormal findings in nipple discharge synovial fluid wound secretions

1.67

0.57

2.0

2.1

787.17

690.19

e6/l

—

Malignant neoplasm of oesophagus

1.67

0.56

2.0

1.7

411.83

679.72

e6/l

—

Thyroiditis

167

1.32

0.56

2.2

2.6

649.27

687.68

e6/l

0.15

161

Rotator cuff syndrome

216

1429

1.08

0.55

2.1

2.6

685.25

669.91

e6/l

0.12

208

1378

Disorders of puberty

1.51

0.54

1.2

2.5

737.00

728.63

e6/l

—

Disorders of puberty, all

1.49

0.53

1.5

3.3

640.18

726.28

e6/l

0.29

Cholecystectomy

243

1947

1.08

0.53

2.4

2.5

714.17

688.38

e6/l

0.25

236

1874

Striking against or struck by other objects

131

1184

1.11

0.53

2.0

2.9

716.93

674.89

e6/l

0.50

122

1157

Malignant neoplasm of corpus uteri

1.52

0.52

1.9

455.70

750.23

e6/l

—

Malignant neoplasm of corpus uteri, including Hilmo

1.45

0.51

2.6

2.0

458.33

765.79

e6/l

2.76

Other specified/unspecified spondylopathies

1.50

0.51

1.8

1016.00

524.63

e6/l

—

Glucosamine medication

134

969

1.10

0.51

2.0

2.3

682.62

662.75

e6/l

0.08

124

918

Unspecified lump in breast

347

0.81

0.50

2.1

2.5

971.14

762.81

e6/l

1.01

332

Sequelae of injuries of lower limb

252

1.23

0.49

1.7

2.6

744.32

690.38

e6/l

0.24

245

Obesity and other hyperalimentation

235

2110

1.07

0.49

2.4

2.6

855.43

673.80

e6/l

5.47

225

2047

Obesity

234

2104

1.07

0.49

2.4

2.6

855.91

673.75

e6/l

5.45

224

2042

Acne

325

1.20

0.49

2.3

2.9

783.36

715.52

e6/l

0.40

318

Bacterial sepsis of newborn

1.50

0.48

2.1

4.2

707.71

731.55

e6/l

—

Insulin, fast-acting (human)

431

0.83

0.47

2.5

2.8

721.14

713.05

e6/l

0.03

419

Glaucoma

172

1365

1.08

0.47

2.4

2.5

662.21

664.40

e6/l

0.01

165

1302

Obesity, other/unspecified

116

1052

1.10

0.47

2.5

2.8

904.80

717.45

e6/l

2.92

110

1026

Patellar tendinitis

1.46

0.47

4.6

2.1

722.86

689.71

e6/l

—

Other benign neoplasms of connective and other soft tissue

236

1.23

0.46

3.0

2.5

852.90

704.54

e6/l

0.84

227

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

101

910

1.11

0.46

2.4

2.8

687.26

658.85

e6/l

0.22

884

Injury of muscle and tendon at wrist and hand level

402

1.17

0.46

2.4

2.8

724.85

648.07

e6/l

0.47

392

Excessive earwax

166

1749

0.93

0.44

2.3

2.6

697.12

675.91

e6/l

0.14

159

1682

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

121

1.32

0.44

2.1

2.6

868.31

728.73

e6/l

0.53

116

Ischaemic heart disease, wide definition

249

1642

0.94

0.43

2.1

2.7

623.90

667.20

e6/l

0.35

233

1583

Arnold-Chiari syndrome

1.62

0.43

2.0

2.1

1433.60

747.77

e6/l

—

Leiomyoma of uterus

187

984

1.08

0.43

2.5

711.92

792.51

e6/l

0.68

177

949

Behavioural disorders, excluding more controls

1.43

0.42

2.4

602.13

646.88

e6/l

—

Prominent ears

1.57

0.42

2.0

1.9

777.20

712.25

e6/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

105

955

1.10

0.42

2.2

2.9

804.03

696.48

e6/l

1.50

105

933

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.42

0.0

3.0

—

1255.13

—

Hypospadias with an incomplete glans penis

0.00

0.41

0.0

3.5

—

572.33

—

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

0.00

0.41

0.0

2.1

—

654.06

—

Mandibular prognathia AND surgery (LeFortI or BSSO)

0.00

0.41

0.0

1.9

—

583.41

—

Defect, injury or illness of neck

0.00

0.41

0.0

2.2

—

510.29

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.41

0.0

2.2

—

592.35

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

0.00

0.40

0.0

1.8

—

769.59

—

Other congenital malformations of nervous system

1.48

0.40

2.0

2.3

1433.60

701.21

e6/l

—

Periapical abscess

166

1544

1.08

0.40

2.8

2.7

732.86

660.32

e6/l

1.21

161

1495

Wet age-related macular degeneration

287

1.18

0.40

1.9

2.0

578.90

611.99

e6/l

0.20

267

Ischaemic Stroke, excluding all haemorrhages

173

1198

1.07

0.40

2.1

2.4

942.73

626.57

e6/l

0.56

166

1143

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.40

0.0

1.9

—

524.50

—

Malignant neoplasm of rectum, including Hilmo

168

1.25

0.40

1.6

1.8

475.90

668.71

e6/l

1.80

161

Obstructed labour due to malposition and malpresentation of fetus

582

0.88

0.39

3.3

2.7

812.15

824.04

e6/l

0.06

569

Measles

1.43

0.39

1.8

2.0

1032.40

673.40

e6/l

—

Complications following myocardial infarction

0.00

0.39

0.0

2.5

—

532.63

—

Glaucoma, exfoliation

178

1.24

0.38

1.8

1.9

577.55

601.61

e6/l

0.08

167

Pregnancy hypertension

108

1055

0.92

0.38

2.3

2.6

888.83

769.55

e6/l

1.62

100

1025

Major coronary heart disease event excluding revascularizations

179

1276

0.93

0.38

1.8

2.5

657.52

655.78

e6/l

0.01

161

1227

Coxarthrosis, primary

183

1450

1.07

0.37

2.3

2.4

657.81

658.53

e6/l

0.00

176

1379

Toxic effect of other and unspecified substances

1.35

0.37

2.2

1.6

829.60

670.08

e6/l

—

Vascular dementia

118

0.73

0.35

1.7

1.9

670.33

590.68

e6/l

—

107

Acute alcohol intoxication

794

1.10

0.35

2.5

2.6

791.48

648.63

e6/l

1.15

768

Complications predominantly related to the puerperium

670

1.11

0.34

2.5

2.7

1543.14

806.58

e6/l

0.60

649

218

1864

1.06

0.33

2.2

2.7

719.55

650.59

e6/l

1.04

206

1807

Sleep disorders

341

2357

1.05

0.33

2.1

2.6

815.43

690.16

e6/l

3.11

326

2288

Other disorders of glucose regulation and pancreatic internal secretion

237

1.18

0.33

1.7

2.5

888.75

777.97

e6/l

0.33

231

Conductive hearing loss, unspecified

210

1.19

0.32

2.0

2.6

675.32

668.65

e6/l

0.03

201

Pedal cyclist injured in noncollision transport accidents

332

1.15

0.32

2.6

2.7

600.00

707.14

e6/l

0.92

325

Stroke, including SAH

204

1400

1.06

0.31

2.1

2.6

893.74

633.89

e6/l

0.53

195

1340

Adenocarcinoma and papilloma adenocarcinoma of rectum

119

1.26

0.31

1.9

1.6

516.00

694.34

e6/l

1.15

114

Oral lichen planus, including avohilmo , including avohilmo

138

1.23

0.30

2.7

2.5

661.59

662.93

e6/l

0.00

133

Foreign body on external eye

476

1.11

0.30

3.5

2.9

612.96

648.71

e6/l

0.22

463

Glaucoma suspect

103

958

1.08

0.29

2.4

700.08

630.87

e6/l

0.80

908

Mental disorders, not otherwise specified

238

0.84

0.28

1.5

2.8

1006.20

688.27

e6/l

3.14

231

Fall on and from stairs and steps

757

1.08

0.28

2.0

2.7

1347.08

681.02

e6/l

0.54

729

Achilles tendinitis

261

1.15

0.27

2.2

2.8

712.23

656.17

e6/l

0.22

256

Mental and behavioural disorders due to alcohol

187

1709

1.05

0.27

2.3

2.7

749.20

647.51

e6/l

1.61

177

1658

Benign lipomatous neoplasm

834

0.92

0.27

2.0

2.7

666.51

669.64

e6/l

0.02

796

Lichen ruber planus, wide definition including periferal and oral lichen planus

566

1.10

0.27

2.4

2.5

818.89

664.70

e6/l

1.18

539

Carcinoma in situ of cervix uteri

225

1.16

0.26

2.6

2.7

747.73

815.61

e6/l

0.29

220

Other disorders originating in the perinatal period

1.24

0.25

1.4

2.9

1415.67

843.33

e6/l

—

Insulin, combination of fast acting with intermediate-acting or long-acting

200

1913

0.95

0.25

2.2

2.7

603.01

658.48

e6/l

0.91

193

1847

Acne vulgaris

255

1.14

0.24

2.7

2.8

748.86

734.04

e6/l

0.06

249

Dislocation, sprain and strain of joints and ligaments of elbow

201

0.84

0.23

4.0

2.7

690.29

729.24

e6/l

0.12

196

Gonarthrosis, primary, with knee surgery

175

1329

1.05

0.23

2.3

2.5

655.09

644.86

e6/l

0.05

163

1270

Personal history of risk-factors, not elsewhere classified

1.32

0.23

3.6

2.4

645.00

537.26

e6/l

—

Transient ischemic attack

156

1202

1.05

0.23

2.3

2.4

634.88

631.77

e6/l

0.03

149

1146

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

125

1.20

0.22

1.9

1.7

516.00

682.34

e6/l

1.05

119

Additional codes for the location of defect, injury or illness

144

1.18

0.22

4.9

2.3

390.82

657.56

e6/l

2.22

139

Digestive system disorders of fetus and newborn

0.00

0.21

0.0

2.8

—

902.10

—

Ebstein's anomaly

0.00

0.21

0.0

3.6

—

817.00

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

0.21

0.0

3.0

—

421.10

—

Effects of other deprivation

0.00

0.21

0.0

1.2

—

614.18

—

Sleepwalking [somnambulism]

0.00

0.21

0.0

1.9

—

973.10

—

Injury of blood vessels at forearm level

0.00

0.21

0.0

2.5

—

486.00

—

Other and unspecified water transport accidents

0.00

0.21

0.0

2.3

—

554.00

—

Profound mental retardation

0.00

0.21

0.0

2.3

—

567.17

—

Malignant neoplasm of hypopharynx, including Hilmo

0.00

0.21

0.0

2.2

—

847.60

—

Alcohol use disorder, ICD-based

148

1412

1.05

0.21

2.2

2.7

744.63

636.38

e6/l

1.40

139

1367

Injury of blood vessels at hip and thigh level

0.00

0.21

0.0

2.8

—

404.42

—

Other hyperalimentation

0.00

0.21

0.0

1.8

—

527.92

—

Meretoja disease

0.00

0.21

0.0

2.1

—

474.25

—

Carcinoma in situ of breast, lobular

0.00

0.21

0.0

1.2

—

465.08

—

Severe mental retardation

0.00

0.21

0.0

3.5

—

548.08

—

Pituitary-dependent Cushing's disease

0.00

0.21

0.0

2.0

—

618.85

—

Cleft hard palate NOS

0.00

0.21

0.0

2.4

—

646.92

—

Congenital absence, occlusion, or narrowing of the ear canal

0.00

0.20

0.0

3.4

—

628.29

—

Balanced rearrangements and structural markers, not elsewhere classified

0.00

0.20

0.0

2.3

—

735.14

—

Other specified acquired deformities of limbs

0.00

0.20

0.0

1.9

—

586.86

—

Benign neoplasm: Brain, unspecified

0.00

0.20

0.0

2.7

—

441.00

—

Early lumbar disc prolapse operation

355

0.90

0.20

1.9

3.0

884.25

710.78

e6/l

0.89

348

Insomnia

328

2319

1.03

0.20

2.2

2.6

821.16

689.76

e6/l

3.23

314

2252

Torsion of ovary, ovarian pedicle and fallopian tube

1.20

0.19

1.3

2.1

1199.17

796.44

e6/l

—

Vestibular neuronitis

212

1.13

0.19

1.5

2.5

562.33

702.76

e6/l

1.06

206

Trigger finger

353

0.91

0.18

2.4

2.8

604.75

660.30

e6/l

0.28

341

Other and/or unspecified nontoxic goitre

164

0.85

0.18

1.3

2.8

936.71

674.14

e6/l

0.55

155

225

1916

1.03

0.18

2.2

2.6

727.93

654.09

e6/l

1.17

213

1859

Malignant neoplasm of breast, ER-positive, including Hilmo

424

1.07

0.18

2.2

2.3

566.25

943.61

e6/l

2.44

404

Other and unspecified disorders of psychological development

1.15

0.17

2.4

3.3

549.29

721.42

e6/l

—

Other aneurysm

110

1.18

0.17

1.6

2.1

661.46

650.20

e6/l

0.02

103

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

186

1.13

0.17

2.0

2.1

622.62

702.38

e6/l

0.36

180

Normotensive glaucoma

148

1.15

0.16

2.1

1.8

762.65

648.04

e6/l

0.43

141

Postpartum haemorrhage due to anatomy

263

1.10

0.16

3.0

2.7

793.24

860.36

e6/l

0.41

256

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

349

0.92

0.15

1.8

2.5

793.31

691.56

e6/l

0.40

335

Malignant neoplasm of breast, HER-positive

417

1.07

0.15

2.0

2.3

542.27

939.04

e6/l

2.64

397

Puerperal sepsis

285

0.91

0.14

2.3

2.6

895.04

743.83

e6/l

0.75

272

Other disorders of amniotic fluid and membranes

364

1.07

0.13

2.9

2.8

803.47

855.10

e6/l

0.33

359

Varicose veins

173

1346

0.97

0.13

2.5

645.64

664.59

e6/l

0.18

164

1299

Meniscus derangement

182

1192

1.03

0.12

2.2

2.7

618.95

636.02

e6/l

0.18

168

1160

Fracture of forearm

185

1651

1.03

0.11

2.0

2.7

736.39

719.27

e6/l

0.12

178

1592

Dipeptidyl peptidase 4 (DPP-4) inhibitors

173

1421

0.97

0.11

2.2

2.5

634.43

651.58

e6/l

0.13

163

1367

Mental and behavioural disorders due to alcohol, excluding acute intoxication

156

1511

1.03

0.11

2.1

2.7

754.58

634.07

e6/l

1.72

146

1463

Fall on same level involving ice and snow

192

1875

1.02

0.11

2.3

2.6

666.13

696.73

e6/l

0.31

181

1816

Divergent concomitant strabismus

222

1.08

0.10

3.9

2.7

808.29

762.03

e6/l

0.18

216

Other articular cartilage disorders

1.09

0.09

2.6

2.5

927.00

595.76

e6/l

—

Erosion and ectropion of cervix uteri

1.06

0.09

1.6

1.7

862.20

667.55

e6/l

—

Postpartum haemorrhage due to retained placenta

309

0.94

0.09

2.0

2.8

803.38

828.17

e6/l

0.11

302

Dislocation, sprain and strain of joints and ligaments of knee

212

1991

0.98

0.09

2.2

2.7

750.53

673.62

e6/l

1.50

203

1941

Toxic effects of substances chiefly nonmedicinal as to source

341

1.06

0.08

3.0

2.7

672.50

700.62

e6/l

0.14

330

Infliximab

1.05

0.08

2.5

2.3

887.00

708.16

e6/l

—

Complications of the puerperium, not elsewhere classified

1.12

0.07

3.8

2.6

914.36

816.85

e6/l

0.28

Myocardial infarction

151

1082

0.98

0.07

1.8

2.6

644.87

602.76

e6/l

0.24

135

1040

Myocardial infarction, with ST-elevation

397

0.96

0.07

1.8

2.2

481.22

584.37

e6/l

0.65

378

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

104

0.86

0.06

3.7

2.9

779.22

737.10

e6/l

—

Lichen sclerosus et atrophicus

192

0.94

0.05

2.1

2.5

666.11

681.97

e6/l

0.05

182

Gonarthrosis,primary

293

1824

0.99

0.05

2.5

684.17

663.26

e6/l

0.15

275

1760

Alcohol use disorder, Swedish definition

197

1783

1.01

0.05

2.1

2.7

731.90

645.45

e6/l

1.29

185

1728

Injury of other and unspecified intrathoracic organs

160

0.94

0.04

3.5

2.5

633.13

716.32

e6/l

0.33

154

Impacted maxillary molar

170

1.06

0.04

3.6

2.6

685.56

813.04

e6/l

0.55

165

Maternal care for known or suspected malpresentation of fetus

403

1.02

0.04

2.7

2.8

701.05

845.74

e6/l

1.89

397

Disorders of breast

137

1228

1.01

0.03

2.8

2.5

860.17

774.94

e6/l

0.75

132

1182

Artificial joint operation, meniscal resection

318

2079

0.99

0.03

2.2

2.6

644.61

670.71

e6/l

0.24

298

2011

Coronary atherosclerosis

208

1326

0.99

0.02

2.1

2.6

613.72

659.99

e6/l

0.31

192

1279

L02BX Other hormone antagonists and related agents

122

1.07

0.02

3.4

2.1

368.31

625.60

e6/l

2.21

115

Crushed, pushed or stepped on by crowd or human stampede

249

0.96

0.02

2.4

2.8

730.25

715.31

e6/l

0.05

244

Poor fetal growth

331

1.03

0.02

2.9

3.0

947.41

857.89

e6/l

0.40

324

Infections of genitourinary tract in pregnancy

212

1.04

0.02

2.1

3.0

764.09

782.39

e6/l

0.07

206

Inflammatory disorders of breast

137

0.95

0.01

2.6

2.4

939.00

765.53

e6/l

0.65

131

Alcohol dependence

851

1.01

0.01

1.9

2.7

662.17

633.71

e6/l

0.25

824

Fall on and from ladder

194

1.03

0.00

2.6

2.4

603.90

643.76

e6/l

0.17

187

Organic, including symptomatic, mental disorders

141

999

1.00

0.00

2.2

2.3

648.67

649.01

e6/l

0.00

135

948

Myocardial infarction, without ST-elevation

103

934

1.00

0.00

1.8

2.4

700.23

584.10

e6/l

0.60

889

Dental pulpitis, including avohilmo

356

2310

1.00

0.00

2.5

2.6

733.01

677.49

e6/l

1.42

347

2242

Injury of muscle and tendon at hip and thigh level

258

1.01

0.00

2.7

593.23

682.53

e6/l

0.52

251

Calcific tendinitis of shoulder

135

1.04

0.00

2.3

2.8

704.21

709.91

e6/l

0.02

129

Early lumbar disc prolapse, operated

322

0.99

0.00

1.9

3.1

884.25

689.66

e6/l

1.04

317

Bicipital tendinitis

119

1.01

0.00

3.8

2.5

644.58

672.29

e6/l

0.06

114

Superficial injury of forearm

285

1.02

0.00

3.4

2.8

742.00

713.89

e6/l

0.14

277

Spermatocele

209

1.00

0.00

2.6

2.4

641.48

528.21

e6/l

0.80

198

Malignant neoplasm of rectum

125

1.04

0.00

1.8

1.7

389.85

682.71

e6/l

2.50

120

Benign lipomatous neoplasm of other sites/unspecified

186

1.02

0.00

2.2

2.0

653.26

710.19

e6/l

0.20

177

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

204

0.98

0.00

2.4

2.9

837.90

813.62

e6/l

0.09

199

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

163

0.98

0.00

1.7

2.3

624.06

678.77

e6/l

0.24

157

Mandibular retrognathia

214

0.98

0.00

3.2

2.7

596.57

683.22

e6/l

0.47

209

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, including Hilmo

0.00

0.0

2.6

—

618.80

—

Other and specified injuries of hip and thigh

0.93

0.00

2.2

1.9

1077.00

565.72

e6/l

—

Pityriasis alba

0.00

0.0

1.3

—

487.67

—

Rifle, shotgun and larger firearm discharge

0.00

0.0

1.5

—

720.50

—

Necrotizing enterocolitis of fetus and newborn

0.00

0.0

3.6

—

1486.20

—

Macular pucker, drug-induced

0.00

0.0

3.0

—

512.40

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

0.0

1.7

—

453.00

—

Sequelae of hyperalimentation

0.00

0.0

1.3

—

638.83

—

Crushing injury of forearm

0.00

0.0

2.0

—

357.33

—

Crushing injury of hip and thigh

0.00

0.0

3.2

—

231.00

—

Abuse of non-dependence-producing substances

0.00

0.0

2.7

—

513.67

—

Other inherited muscular atrophy

0.00

0.0

3.0

—

625.17

—

Forearm

0.00

0.0

2.0

—

511.40

—

Labyrinthine dysfunction

0.00

0.0

2.9

—

501.57

—

Endometroid carcinoma of ovary, including Hilmo

0.00

0.0

1.0

—

1037.29

—

Vaginal lichen planus

0.00

0.0

1.3

—

434.50

—

Physical medicine devices associated with adverse incidents

0.00

0.0

1.8

—

463.00

—

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

0.00

0.0

2.6

—

467.56

—

Familial benign pemphigus (Hailey-Hailey disease)

0.00

0.0

3.3

—

406.12

—

Congenital glaucoma

0.00

0.0

1.7

—

541.00

—

Fractures involving multiple body regions

0.00

-0.00

0.0

3.0

—

413.83

—

Poikiloderma of Civatte

0.00

-0.00

0.0

1.2

—

535.67

—

Retarded development following protein-energy malnutrition

0.00

-0.00

0.0

3.2

—

601.50

—

conjunctival scars

0.00

-0.00

0.0

1.8

—

430.38

—

Drug-induced thyroiditis

0.00

-0.00

0.0

2.8

—

447.00

—

Injury of heart

0.00

-0.00

0.0

2.7

—

410.83

—

Exclusion endpoint for supernumerary teeth

0.92

-0.00

1.4

2.4

1327.60

787.72

e6/l

—

Degenerative and vascular disorders of ear

0.00

-0.00

0.0

3.2

—

552.50

—

Traumatic cerebral oedema

0.00

-0.00

0.0

2.8

—

392.80

—

Toxic erythema

0.00

-0.00

0.0

2.4

—

495.14

—

Café au lait spots

0.00

-0.00

0.0

2.4

—

799.00

—

Victim of lightning

0.00

-0.00

0.0

1.2

—

564.40

—

Cutaneous autosensitization

0.00

-0.00

0.0

2.4

—

477.20

—

Intentional self-harm by smoke, fire and flames

0.00

-0.00

0.0

2.2

—

435.83

—

Irritant contact dermatitis due to drugs in contact with skin

0.00

-0.00

0.0

3.2

—

459.80

—

Cholera

0.00

-0.00

0.0

1.7

—

459.43

—

Intentional self-harm by jumping or lying before moving object

0.00

-0.00

0.0

1.4

—

482.40

—

Exposure to high-pressure jet

0.00

-0.00

0.0

1.6

—

517.80

—

Alzheimer’s disease (undefined)

0.00

-0.00

0.0

1.4

—

558.40

—

Secondary lactase deficiency

0.00

-0.00

0.0

2.0

—

327.60

—

Exposure to electric transmission lines

0.00

-0.00

0.0

3.2

—

352.67

—

Injury of blood vessels of thorax

0.00

-0.00

0.0

3.3

—

516.14

—

Klinefelter syndrome, karyotype 47 XXY

0.00

-0.00

0.0

2.7

—

446.67

—

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

0.00

-0.00

0.0

2.0

—

673.80

—

Malignant neoplasm of renal pelvis

0.00

-0.00

0.0

2.7

—

990.33

—

Macrocephaly

0.00

-0.00

0.0

3.1

—

1199.89

—

Underdevelopment of the second kidney

0.00

-0.00

0.0

3.7

—

571.25

—

Brain mixed glioma

0.00

-0.00

0.0

2.4

—

657.29

—

Glycosuria

0.00

-0.00

0.0

1.4

—

453.14

—

Keratoconus

1.01

-0.00

1.3

2.0

765.43

608.17

e6/l

—

Other conditions originating in the perinatal period

0.00

-0.00

0.0

5.0

—

520.86

—

Other birth injuries

0.00

-0.00

0.0

2.6

—

548.20

—

Intracranial laceration and haemorrhage due to birth injury

0.00

-0.00

0.0

2.4

—

689.00

—

Other perinatal digestive system disorders

0.00

-0.00

0.0

1.9

—

862.00

—

Huntington disease

0.00

-0.00

0.0

1.6

—

581.80

—

Non-seminoma of testis

0.00

-0.00

0.0

2.8

—

406.33

—

Benign neoplasm: Renal pelvis

0.00

-0.00

0.0

3.2

—

459.80

—

Airway disease due to specific organic dust

0.00

-0.00

0.0

2.8

—

449.17

—

Benign neoplasm: Female genital organ, unspecified

0.00

-0.00

0.0

1.3

—

366.57

—

Malignant neoplasm of hypopharynx

0.00

-0.00

0.0

2.7

—

649.86

—

Explosion and rupture of other specified pressurized devices

0.00

-0.00

0.0

3.3

—

423.50

—

Obstetric embolism

0.00

-0.00

0.0

1.1

—

470.86

—

Infections specific to the perinatal period

1.01

-0.00

2.0

3.6

724.38

782.81

e6/l

—

Spina bifida

0.00

-0.00

0.0

1.4

—

644.14

—

Birth injury to peripheral nervous system

0.00

-0.00

0.0

2.7

—

357.57

—

Birth injury to scalp

0.00

-0.00

0.0

1.8

—

1456.60

—

Benign neoplasm: Pineal gland

0.00

-0.00

0.0

1.3

—

687.00

—

Chondrosarcoma

0.00

-0.00

0.0

1.4

—

738.80

—

Other drug-induced osteomalacia in adults

0.00

-0.00

0.0

2.0

—

555.00

—

Carcinoma in situ of oesophagus

0.00

-0.00

0.0

3.1

—

478.44

—

Dysplastic lesion of the vagina of unknown severity

0.00

-0.00

0.0

1.2

—

529.60

—

Nephropathy induced by unspecified drug, medicament or biological substance

0.00

-0.00

0.0

4.2

—

418.60

—

Exposure to high and low air pressure and changes in air pressure

0.00

-0.00

0.0

2.0

—

373.40

—

Acrodermatitis chronica atrophicans

0.00

-0.00

0.0

1.6

—

336.80

—

Alkalosis

0.00

-0.00

0.0

1.8

—

275.33

—

Drug-induced dystonia

0.00

-0.00

0.0

1.6

—

587.63

—

Disorders of amino-acid transport

0.00

-0.00

0.0

2.6

—

477.43

—

Follicular keratosis (Darier-White)

0.00

-0.00

0.0

2.0

—

473.60

—

Maternal care for (suspected) damage to fetus from alcohol

0.00

-0.00

0.0

1.7

—

950.56

—

Disease of thymus, other/unspecified

0.00

-0.00

0.0

2.4

—

368.86

—

Mucinous and mucinous cystic tumor of rectum

0.00

-0.00

0.0

2.4

—

997.71

—

Malignant neoplasm of meninges, including Hilmo

0.00

-0.00

0.0

2.6

—

744.80

—

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

0.00

-0.00

0.0

2.6

—

376.60

—

Nightmares

0.00

-0.00

0.0

2.5

—

632.00

—

Diseases of thymus

0.00

-0.00

0.0

2.4

—

368.86

—

Lipomatosis, not elsewhere classified

0.00

-0.00

0.0

1.4

—

571.29

—

Malignant neoplasm of other and ill-defined sites

0.00

-0.00

0.0

1.4

—

765.20

—

Staphylococcal scalded skin syndrome

0.00

-0.00

0.0

1.8

—

439.80

—

Hyperalimentation, other specified

0.00

-0.00

0.0

2.2

—

626.33

—

Lichen nitidus

0.00

-0.00

0.0

3.0

—

343.80

—

Other disorders of prostate

1.01

-0.00

2.0

628.86

500.79

e6/l

—

Ovarian dysfunction: estrogen excess

0.00

-0.00

0.0

1.2

—

633.20

—

Adenocarcinomas of cervix

0.00

-0.00

0.0

1.2

—

967.83

—

Transepidermal elimination disorders

0.00

-0.00

0.0

1.0

—

483.17

—

Other and unspecified cicatricial alopecia

0.00

-0.00

0.0

1.5

—

514.67

—

Injury of muscle and tendon at neck level

0.00

-0.00

0.0

1.6

—

590.00

—

Benign muscular dystrophy (Becker)

0.00

-0.00

0.0

3.6

—

248.60

—

Supernumerary ureter

0.00

-0.00

0.0

2.8

—

579.60

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

CD3+CD4+ (T4 helper) cells [#/volume] in Blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS